Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,"GPCRs, Class A Rhodopsin-like WP455",1.588091395370663e-08,2.6084047485248667,46.84211807193698,"['GPR27', 'OXTR', 'CHRM1', 'GPR68', 'GPR65', 'NPY2R', 'HTR2B', 'GPR20', 'ADRA1D', 'MC4R', 'HTR7', 'CYSLTR2', 'ADORA3', 'GPR171', 'C3AR1', 'CCR9', 'PTGDR', 'GPR39', 'AVPR1A', 'SSTR1', 'ADRA2C', 'SSTR3', 'ADRA2A', 'TRHR', 'CCKBR', 'ADORA2A', 'FSHR', 'OR7A5', 'OR3A3', 'GPR87', 'CXCR5', 'OPRL1', 'CXCR4', 'GPR83', 'MCHR1', 'HRH1', 'HRH3', 'CNR2', 'OR2AG1', 'RHO', 'DRD1', 'DRD3', 'NTSR1', 'DRD5', 'CCR1', 'OPN4', 'GPR12', 'P2RY14', 'HTR1D', 'GPR4', 'GPR3', 'GPR6', 'HTR5A', 'HCRTR2', 'HCRTR1', 'MAS1', 'OPN1SW', 'ACKR4', 'ACKR3', 'RGL4', 'OR7C1', 'GPR18', 'F2RL2']",9.05212095361278e-06,0,0,63
2,Apoptosis Modulation and Signaling WP1772,3.208214916340297e-05,2.5858631335219964,26.756470899415728,"['HRK', 'BCL2A1', 'TNFRSF11B', 'CASP7', 'BCL2L10', 'CASP8', 'CAPNS1', 'CASP6', 'BAG3', 'CASP4', 'PEA15', 'CASP1', 'PMAIP1', 'BMF', 'MAPK3', 'DAXX', 'JUN', 'ENDOG', 'IL1R1', 'BIK', 'CDKN2A', 'BAD', 'IL1R2', 'BNIP3', 'TNFRSF10C', 'TNFRSF10A', 'TNFRSF1B', 'TNFRSF1A', 'TNFRSF10D', 'NFKBIA', 'TOLLIP', 'CYCS', 'BCL2L2', 'HSPA1A']",0.00515978079229173,0,0,34
3,Complement system WP2806,4.126420437724177e-05,2.6358402971216344,26.61016566817282,"['FCN1', 'CFH', 'C1R', 'CFI', 'ITGB2', 'ICAM2', 'F13A1', 'C4BPA', 'PLG', 'FCGR3A', 'C6', 'C7', 'C1QBP', 'C3AR1', 'SPP1', 'CD59', 'VSIG4', 'ELANE', 'PRNP', 'CR2', 'CR1', 'CD93', 'F10', 'F12', 'F11', 'LAMB1', 'SELE', 'SELP', 'ALB', 'MASP2', 'CALR', 'TLR2']",0.00515978079229173,0,0,32
4,Glycolysis and Gluconeogenesis WP534,4.132446194118955e-05,3.760080378625631,37.95446166013394,"['TPI1', 'PKLR', 'GOT1', 'MDH2', 'PGAM1', 'PGAM2', 'SLC2A2', 'ENO1', 'ENO2', 'SLC2A5', 'LDHC', 'HK3', 'LDHA', 'PKM', 'PGK1', 'ALDOC', 'ALDOB', 'ALDOA', 'GAPDH', 'FBP2']",0.00515978079229173,0,0,20
5,Spinal Cord Injury WP2431,4.680439911596832e-05,2.337908811813361,23.307859894942478,"['RTN4R', 'C1QB', 'CDKN1B', 'XYLT1', 'AQP4', 'CXCL1', 'CXCL2', 'AIF1', 'NTN1', 'AQP1', 'TNFSF13B', 'LGALS3', 'ACAN', 'GJA1', 'ZFP36', 'SLIT3', 'SOX9', 'RAC1', 'ROS1', 'MAPK3', 'NGFR', 'EGR1', 'IL1R1', 'BDNF', 'ARG1', 'MIF', 'LILRB2', 'PDYN', 'LILRB3', 'GFAP', 'RHOB', 'SELP', 'FKBP1A', 'NR4A1', 'VCAN', 'FCGR2A', 'LEP', 'CDK2', 'VIM']",0.00515978079229173,0,0,39
6,Proximal tubule transport WP4917,5.431348202412347e-05,3.2441749692374864,31.860192639450958,"['SLC47A2', 'ATP6V1G1', 'SLC13A3', 'ATP6V0B', 'SLC22A6', 'ABCC2', 'ABCB1', 'SLC2A2', 'SLC3A1', 'SLC4A2', 'ATP1A1', 'SLC5A1', 'ATP1B1', 'SLC5A2', 'AQP1', 'SLC5A5', 'ATP6V0A4', 'ATP6V1E1', 'SLC22A8', 'ATP6V0C', 'ABCG2', 'ATP6V1B1', 'ATP6V1F']",0.00515978079229173,0,0,23
7,Selenium Micronutrient Network WP15,7.092093749666411e-05,2.634929472902747,25.17397088823251,"['SERPINA3', 'SAA4', 'PLG', 'SELENOH', 'PRDX3', 'PRDX2', 'PRDX5', 'KYNU', 'RFK', 'ALOX5', 'PRDX1', 'PNPO', 'SEPHS2', 'XDH', 'GGT2', 'GPX2', 'GPX4', 'GPX3', 'DIO1', 'DIO3', 'KMO', 'SOD3', 'SOD1', 'SELENOM', 'SELENOP', 'ALOX5AP', 'ALB', 'SELENOW', 'SELENOV', 'SAA2']",0.0057749906247283635,0,0,30
8,Vitamin D Receptor Pathway WP2877,8.507416939546572e-05,2.067269619269619,19.37442420572936,"['COLEC11', 'CEBPA', 'ABCB1', 'CDKN1B', 'COL13A1', 'PTH', 'SATB1', 'TNFAIP3', 'TNFRSF11B', 'CLDN2', 'CYP3A5', 'THBD', 'SULT1C2', 'IL1RL1', 'CASP5', 'BGLAP', 'CLMN', 'ALOX5', 'DND1', 'CREG2', 'BTLA', 'TIMP2', 'SPP1', 'SOSTDC1', 'KRTAP5-1', 'LGALS9', 'CD14', 'CDKN2D', 'LRRC25', 'CDKN2C', 'IGFBP5', 'CDKN2A', 'IGFBP3', 'NFATC2', 'G0S2', 'CEACAM1', 'TRPV6', 'BCL6', 'TRPV5', 'CDK2', 'PNOC', 'S100A6', 'IRF8', 'S100A4', 'S100A9', 'S100A8', 'NOX1']",0.006061534569426932,0,0,47
9,"GPCRs, Other WP117",0.00010208664038684332,2.7351449662993472,25.13513076141429,"['GPR88', 'OR2M4', 'ADRA1D', 'GPR83', 'GPR84', 'CELSR1', 'CELSR2', 'ADGRE2', 'GPR132', 'PROKR2', 'HTR7', 'ADORA3', 'ADGRE3', 'HRH4', 'GNRHR', 'S1PR1', 'DRD3', 'NTSR1', 'GPR55', 'GPR162', 'CCKBR', 'ADORA2A', 'FSHR', 'OR10A2', 'ACKR1', 'OR3A3', 'GPR18']",0.006465487224500077,0,0,27
10,Nuclear Receptors Meta-Pathway WP2882,0.00019768344270861132,1.6632199810675017,14.18534305910557,"['CDKN1C', 'SERPINA1', 'CDKN1B', 'HSP90AB1', 'SRXN1', 'KEAP1', 'TNFAIP3', 'SLC2A2', 'SLC7A11', 'SLC2A5', 'SLC6A4', 'THBD', 'RGS2', 'ZIC2', 'SLCO2B1', 'ENC1', 'PDK4', 'SLC39A5', 'SLC39A7', 'GGT2', 'SLC39A3', 'SRGN', 'HSP90AA1', 'GPX2', 'SERPINB2', 'ABCC2', 'GPX3', 'TSC22D3', 'HGF', 'MYOF', 'CYP4A11', 'AIP', 'SLC39A12', 'CES4A', 'TGFBR2', 'TGFBR3', 'CYP2A6', 'B3GNT5', 'ANGPTL4', 'EPHA2', 'FKBP5', 'ABCB1', 'GSTP1', 'NR1I3', 'AMIGO2', 'SLC5A11', 'SLC5A1', 'SLC5A2', 'ABCB11', 'CYP2C19', 'SLC5A3', 'CYP3A5', 'SLC5A4', 'SLC5A5', 'CYP3A7', 'PTPA', 'PRRG4', 'SLCO1B1', 'DNAJB1', 'PRDX1', 'HMOX1', 'STOM', 'HES1', 'IP6K3', 'CBR3', 'EGR1', 'JUN', 'JUND', 'SLC10A1', 'PLK2', 'SOD3', 'FASN', 'BHLHE40', 'ALOX5AP', 'SPINK13', 'ACKR3', 'GSTM5', 'HSPA1A']",0.011267956234390844,0,0,78
11,Complement and Coagulation Cascades WP558,0.0003414891534095739,2.8014516129032256,22.361732051731998,"['C1QB', 'C1QA', 'CR2', 'SERPINA1', 'CR1', 'VWF', 'CFH', 'SERPIND1', 'F10', 'C1R', 'F12', 'CFI', 'PLG', 'TFPI', 'CLU', 'F5', 'THBD', 'C6', 'C7', 'C3AR1', 'MASP2', 'C1QC']",0.016245451065661217,0,0,22
12,Macrophage markers WP4146,0.00034200949611918355,13.786998616874136,110.0295145820366,"['CD86', 'CD74', 'CD163', 'CD83', 'CD14', 'LYZ', 'CD68']",0.016245451065661217,0,0,7
13,Peptide GPCRs WP24,0.00038203309289699337,2.858142853038907,22.493593749565854,"['CCR1', 'OXTR', 'NPY2R', 'CXCR5', 'OPRL1', 'CXCR4', 'SSTR1', 'AVPR1A', 'SSTR3', 'HCRTR2', 'TRHR', 'HCRTR1', 'MC4R', 'CCKBR', 'FSHR', 'C3AR1', 'GNRHR', 'CCR9', 'TAC4', 'ACKR1', 'NTSR1']",0.016750681765483555,0,0,21
14,Computational Model of Aerobic Glycolysis WP4629,0.0006378160390653146,7.8793580520199225,57.972066864010614,"['LDHA', 'TPI1', 'PKM', 'PGAM2', 'PGK1', 'ENO1', 'ALDOA', 'GAPDH']",0.025968224447659238,0,0,8
15,Sleep regulation WP3591,0.0010288804569311323,3.4500415742793793,23.73381581128411,"['CHRNB2', 'OXTR', 'AHCY', 'NPY2R', 'IL18', 'HCRTR2', 'HCRTR1', 'ADORA2A', 'CRH', 'UTS2', 'GHRL', 'DRD1', 'DRD3', 'PTGDR']",0.03909745736338303,0,0,14
16,Pathogenic Escherichia coli infection WP2272,0.0014646724297381,2.5453601046013863,16.611334799219996,"['TUBB', 'ARPC5L', 'LY96', 'ARPC4', 'TUBB4B', 'TUBB4A', 'ACTB', 'TUBA4A', 'ACTG1', 'TUBB8', 'TUBA1B', 'TUBB6', 'TUBA3D', 'TUBA1A', 'TUBB2A', 'TUBB3', 'TUBB1', 'HCLS1', 'CD14', 'TLR5']",0.050624172066687144,0,0,20
17,NRF2 pathway WP2884,0.0015098437283047042,1.8769391741071428,12.192125997321284,"['SERPINA1', 'HSP90AB1', 'SRXN1', 'GSTP1', 'SLC5A11', 'KEAP1', 'SLC2A2', 'SLC5A1', 'SLC7A11', 'SLC5A2', 'SLC2A5', 'SLC5A3', 'SLC5A4', 'SLC5A5', 'SLC6A4', 'DNAJB1', 'PRDX1', 'SLC39A5', 'HMOX1', 'SLC39A7', 'GGT2', 'SLC39A3', 'CBR3', 'EGR1', 'HSP90AA1', 'GPX2', 'ABCC2', 'GPX3', 'HGF', 'CYP4A11', 'SLC39A12', 'SOD3', 'CES4A', 'TGFBR2', 'CYP2A6', 'EPHA2', 'GSTM5', 'HSPA1A']",0.050624172066687144,0,0,38
18,Gastric acid production WP2596,0.0016877057098801146,inf,inf,"['GRP', 'CCK', 'VIP', 'MUC6']",0.05344401414620363,0,0,4
19,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.004100878822459154,2.1102567250592865,11.599140003688964,"['PSMD10', 'HSPA8', 'HSPA1L', 'HSPA5', 'TUBB', 'UBE2L6', 'TUBB4B', 'TUBB4A', 'TUBA4A', 'PSMD8', 'TUBB8', 'TUBA1B', 'TUBB6', 'TUBA3D', 'CASP8', 'TUBA1A', 'TUBB2A', 'TUBB3', 'TUBB1', 'CASP1', 'STUB1', 'HSPA1B', 'HSPA1A']",0.12302636467377463,0,0,23
20,Drug Induction of Bile Acid Pathway WP2289,0.004616991257580827,4.501541623843782,24.20934500201827,"['SLCO1B1', 'ABCB1', 'ABCC2', 'SLC10A1', 'NR1I3', 'SLC51A', 'SLC51B', 'ABCB11']",0.13020204390539428,0,0,8
21,Glucocorticoid Receptor Pathway WP2880,0.0047969174070408415,2.116680216802168,11.302610443570234,"['CDKN1C', 'SRGN', 'HSP90AA1', 'JUN', 'TSC22D3', 'NR1I3', 'PLK2', 'AMIGO2', 'TNFAIP3', 'TGFBR3', 'PRRG4', 'THBD', 'RGS2', 'ZIC2', 'B3GNT5', 'ENC1', 'ALOX5AP', 'BHLHE40', 'STOM', 'SPINK13', 'ACKR3', 'ANGPTL4']",0.13020204390539428,0,0,22
22,TYROBP causal network in microglia WP3945,0.00657316332200769,2.1316986058796163,10.71127406296258,"['RBM47', 'IGSF6', 'IL10RA', 'ITGB2', 'GIMAP2', 'RNASE6', 'IL18', 'CAPG', 'TCIRG1', 'SLC1A5', 'TNFRSF1B', 'RUNX3', 'SAMSN1', 'CXCL16', 'TYROBP', 'RGS1', 'ELF4', 'SPP1', 'HCLS1', 'C1QC']",0.1675489695175338,0,0,20
23,Inflammatory Response Pathway WP453,0.006760747892812767,3.2830380214101145,16.404099216735663,"['CD86', 'ZAP70', 'COL3A1', 'IL4R', 'IL5', 'LAMB2', 'CD80', 'LAMB1', 'TNFRSF1B', 'TNFRSF1A']",0.1675489695175338,0,0,10
24,Zinc homeostasis WP3529,0.009143211329368128,2.561457467442505,12.02538606802997,"['SLC30A3', 'SLC30A2', 'MT1M', 'MT1X', 'SLC39A12', 'MT2A', 'MT1A', 'MT1F', 'SLC39A5', 'MT1G', 'SLC39A7', 'SLC39A3', 'MT1E']",0.21715126907249305,0,0,13
25,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.010401369984674292,2.398847970693146,10.952702649455086,"['HSP90AA1', 'CARD6', 'IL18', 'NOD2', 'NFKBIA', 'CASP7', 'NLRP12', 'CASP8', 'CASP5', 'NLRP7', 'CASP1', 'RAC1', 'NLRP1', 'AAMP']",0.22988664612753468,0,0,14
26,Monoamine GPCRs WP58,0.010535913911997203,2.6267774699907664,11.959627158740602,"['HRH1', 'CHRM1', 'HTR7', 'HTR1D', 'HTR2B', 'ADRA1D', 'DRD1', 'HTR5A', 'ADRA2C', 'DRD3', 'ADRA2A', 'DRD5']",0.22988664612753468,0,0,12
27,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.01088936744814638,3.222680723649448,14.566415128589723,"['BCL6', 'H2AFZ', 'H3F3A', 'H2AFX', 'PCGF1', 'H2AFV', 'DUSP6', 'HIST1H3E', 'MAPK3']",0.22988664612753468,0,0,9
28,Blood Clotting Cascade WP272,0.011847437310288858,3.5007071266064074,15.527889496007084,"['F8A1', 'SERPINB2', 'VWF', 'F10', 'F12', 'F11', 'PLG', 'F5']",0.2373474373204083,0,0,8
29,Glycolysis in senescence WP5049,0.012450037647924322,4.72466814159292,20.722543920420552,"['LDHA', 'PKM', 'PGK1', 'ALDOC', 'ENO1', 'GAPDH']",0.2373474373204083,0,0,6
30,Cytokines and Inflammatory Response WP530,0.012491970385284648,3.9377593360995853,17.25789659973195,"['IL5', 'CSF1', 'IL15', 'IL7', 'HLA-DRA', 'CXCL1', 'CXCL2']",0.2373474373204083,0,0,7
31,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.013410792263679052,1.5709558174372178,6.773483134034098,"['TPH1', 'DLX2', 'CEBPB', 'YWHAB', 'CDCA7L', 'ATP1A3', 'AQP4', 'GATA2', 'SLC6A4', 'NEUROD1', 'GJA1', 'HES1', 'TPPP', 'SCN3B', 'TAC1', 'YWHAG', 'HES5', 'YWHAH', 'NKX3-1', 'CHRNB2', 'EGR1', 'GABRA1', 'JUN', 'TSPYL1', 'BDNF', 'SSTR1', 'POU3F2', 'RUNX3', 'VEGFA', 'ADCYAP1', 'PRKAR1A', 'SST', 'PAH', 'BHLHE40', 'CHRFAM7A', 'ALDOA', 'GAPDH', 'SLC25A4', 'VAMP2']",0.2465855351708729,0,0,39
32,Thyroxine (Thyroid Hormone) Production WP1981,0.017802883144895615,7.871752349364289,31.71052670627042,"['TPO', 'TRH', 'CGA', 'SLC5A5']",0.31565932816136805,0,0,4
33,Circadian rhythm related genes WP3594,0.0186625034688364,1.4579139942318453,5.804303950784566,"['TPH1', 'MAGEL2', 'AHCY', 'CHRM1', 'NPY2R', 'BHLHE41', 'OPRL1', 'SLC6A4', 'RELB', 'ATOH7', 'PPP1CC', 'PROKR2', 'HTR7', 'AANAT', 'DBP', 'NFIL3', 'NOCT', 'UBC', 'SIX3', 'DRD1', 'DRD3', 'SKP1', 'CHRNB2', 'KLF10', 'NTRK1', 'EGR1', 'NGFR', 'JUN', 'OPN4', 'EGR3', 'JUND', 'HOMER1', 'NR1D1', 'CARTPT', 'HCRTR2', 'NR2F6', 'HCRTR1', 'HS3ST2', 'PER2', 'ADORA2A', 'ID2', 'LEP', 'BHLHE40', 'CRH', 'ID3', 'UTS2', 'GHRL', 'UBA52']",0.31565932816136805,0,0,48
34,Hematopoietic Stem Cell Differentiation WP2849,0.019246337917439883,2.034029305995384,8.035299492346041,"['CSF1', 'LEF1', 'RHOH', 'CXCR4', 'NFATC2', 'IKZF1', 'GATA2', 'GATA1', 'ABO', 'FLI1', 'RUNX1', 'MUC1', 'TPO', 'IL5', 'PIM1', 'CD34']",0.31565932816136805,0,0,16
35,Cori Cycle WP1946,0.01938259032569804,3.4452973720608577,13.586116825850057,"['LDHA', 'TPI1', 'PGAM1', 'PGK1', 'SLC2A2', 'ALDOA', 'GAPDH']",0.31565932816136805,0,0,7
36,Fatty Acid Omega Oxidation WP206,0.02071339881113068,4.920514238319049,19.076708241386797,"['ADH4', 'CYP2A6', 'ADH1B', 'CYP4A11', 'ALDH1A1']",0.32796214784290245,0,0,5
37,Cell migration and invasion through p75NTR WP4561,0.021620566348384405,2.407212529616296,9.229518285573747,"['EFNA1', 'NGFR', 'ARF1', 'JUN', 'EFNA3', 'EFNB3', 'BDNF', 'PARD3', 'CDH11', 'RAC1', 'EFNA4']",0.33307358969132733,0,0,11
38,Constitutive Androstane Receptor Pathway WP2875,0.029606880370875107,2.531572496144874,8.910498495190918,"['PTPA', 'HSP90AA1', 'CYP2A6', 'ABCB1', 'ABCC2', 'NR1I3', 'CYP4A11', 'CYP2C19', 'CYP3A5']",0.4441032055631266,0,0,9
39,Control of immune tolerance by vasoactive intestinal peptide WP4484,0.03491812500851412,5.247466371844482,17.60393384053676,"['CD86', 'IL5', 'CD80', 'VIP']",0.5103418270475141,0,0,4
40,Microglia Pathogen Phagocytosis Pathway WP3937,0.03906410405039162,1.969520642837351,6.38627169843254,"['C1QB', 'LYN', 'C1QA', 'FCER1G', 'NCF4', 'ITGB2', 'CYBA', 'HCK', 'TYROBP', 'RAC1', 'FCGR1A', 'SIGLEC7', 'C1QC']",0.5459314574420868,0,0,13
41,Cancer immunotherapy by PD-1 blockade WP4585,0.04022652844310114,2.755850622406639,8.85517800826179,"['ZAP70', 'JUN', 'CD8B', 'NFATC2', 'NFATC1', 'PDCD1LG2', 'BATF']",0.5459314574420868,0,0,7
42,Simplified Depiction of MYD88 Distinct Input-Output Pathway WP3877,0.04022652844310114,2.755850622406639,8.85517800826179,"['TLR1', 'JUN', 'TIFA', 'TLR9', 'TLR6', 'TLR5', 'TLR2']",0.5459314574420868,0,0,7
43,Ovarian infertility WP34,0.042381320597859796,2.1877691645133504,6.915642391914422,"['EGR1', 'CEBPB', 'CDKN1B', 'FSHR', 'GJA4', 'MSH5', 'PGR', 'ZP3', 'INHA', 'PRLR']",0.561798900948374,0,0,10
44,Biogenic Amine Synthesis WP550,0.053068410608523776,3.2798820385217953,9.63030250013886,"['TPH1', 'AANAT', 'GAD1', 'PAH', 'ASMT']",0.6712771406346688,0,0,5
45,Development of pulmonary dendritic cells and macrophage subsets WP3892,0.053068410608523776,3.2798820385217953,9.63030250013886,"['TPO', 'CSF1', 'ID2', 'IRF8', 'IKZF1']",0.6712771406346688,0,0,5
46,Complement Activation WP545,0.05462794407181705,2.5051427134414688,7.282975273978494,"['C1QB', 'C1QA', 'C6', 'C7', 'C1R', 'MASP2', 'C1QC']",0.6712771406346688,0,0,7
47,Allograft Rejection WP2328,0.05535092212250778,1.6492140515706064,4.772927650745369,"['CD86', 'C1QB', 'C1QA', 'ABCB1', 'CD80', 'CXCR5', 'HLA-E', 'VEGFA', 'TUBA1B', 'CASP7', 'CASP8', 'C6', 'IL5', 'C7', 'HLA-DRA', 'VIM', 'HLA-DQB1', 'C1QC']",0.6712771406346688,0,0,18
48,HIF1A and PPARG regulation of glycolysis WP2456,0.05880133078917444,3.9353233830845773,11.15109610131835,"['LDHA', 'TPI1', 'GPD1', 'GAPDH']",0.6850331449941257,0,0,4
49,Eicosanoid Synthesis WP167,0.060090626753870675,2.2496640050596883,6.325833388839453,"['PTGES2', 'ALOX5', 'ALOX15', 'ALOX5AP', 'TBXAS1', 'ALOX12', 'GGT2', 'PTGES']",0.6850331449941257,0,0,8
50,Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling WP3612,0.060090626753870675,2.2496640050596883,6.325833388839453,"['JUN', 'ABCC2', 'SRXN1', 'GSTP1', 'EPHX1', 'KEAP1', 'HMOX1', 'ABCG2']",0.6850331449941257,0,0,8
51,Metapathway biotransformation Phase I and II WP702,0.062111935359985083,1.3963326830174656,3.8801531545870334,"['GSTP1', 'AKR1D1', 'GLYAT', 'CYP2C19', 'CYP2C18', 'NAT14', 'CYP3A5', 'CYP3A7', 'SULT1C2', 'CYP26B1', 'CHST13', 'GAL3ST2', 'SULT4A1', 'GAL3ST3', 'HS3ST3B1', 'CHST8', 'CHST9', 'GPX2', 'GPX4', 'GPX3', 'EPHX1', 'CYP4F11', 'HS3ST2', 'CYP39A1', 'CYP26A1', 'SULT1B1', 'CYP2A6', 'CYP21A2', 'CHST1', 'NAT8L', 'CHST4', 'CHST2', 'GSTM5', 'CHST3']",0.694192218729245,0,0,34
52,Development and heterogeneity of the ILC family WP3893,0.06458970990620243,2.6240781710914454,7.189187412112559,"['IL5', 'NFIL3', 'IL15', 'IL7', 'ID2', 'IL18']",0.6946440499346299,0,0,6
53,ID signaling pathway WP53,0.06458970990620243,2.6240781710914454,7.189187412112559,"['PAX8', 'ID2', 'CDK2', 'ID3', 'ELK1', 'PAX2']",0.6946440499346299,0,0,6
54,Myometrial relaxation and contraction pathways WP289,0.06719401786199691,1.3634041111067663,3.6814243175233745,"['RGS18', 'OXTR', 'RGS14', 'YWHAB', 'ADCY4', 'RXFP2', 'ETS2', 'ACTB', 'ACTG1', 'RGS4', 'GJA1', 'RGS2', 'GNG3', 'RGS1', 'IGFBP6', 'YWHAG', 'CORIN', 'YWHAH', 'JUN', 'PRKCH', 'IGFBP5', 'IGFBP4', 'IGFBP3', 'IGFBP2', 'GNG11', 'GNG13', 'CREB3', 'ACTA1', 'ACTC1', 'PRKAR1A', 'GNB2', 'GNAS', 'CRH', 'ACKR3', 'CALM3', 'CALM1', 'CALM2']",0.7027650694642924,0,0,37
55,Oxidative Damage WP3941,0.06781066459743172,1.8175154485403793,4.890999141725101,"['C1QB', 'CDKN1C', 'C1QA', 'CR2', 'CDKN1B', 'C1R', 'BAD', 'C3AR1', 'CYCS', 'TNFRSF1B', 'NFKBIE', 'C1QC']",0.7027650694642924,0,0,12
56,Transcriptional cascade regulating adipogenesis WP4211,0.07620353729474791,2.8111299814368658,7.236825148024421,"['CEBPA', 'CEBPB', 'CEBPD', 'GATA2', 'KLF15']",0.7756431474643983,0,0,5
57,Hypertrophy Model WP516,0.08621894370794476,2.361504424778761,5.78772939421701,"['JUND', 'NR4A3', 'MSTN', 'IL1R1', 'IL18', 'VEGFA']",0.8561328152141099,0,0,6
58,Bile acids synthesis and enterohepatic circulation  WP4389,0.08927170317774209,3.148037589828635,7.60588143058052,"['SLC10A1', 'FGFR4', 'ABCB11', 'MAPK3']",0.8561328152141099,0,0,4
59,Irinotecan pathway WP229,0.08927170317774209,3.148037589828635,7.60588143058052,"['SLCO1B1', 'ABCC2', 'CYP3A5', 'ABCG2']",0.8561328152141099,0,0,4
60,Senescence and Autophagy in Cancer WP615,0.0927852211334551,1.4071249851066365,3.3453944930879356,"['CEBPB', 'CDKN1B', 'CXCL1', 'BMI1', 'CXCL14', 'GABARAP', 'MAP1LC3B', 'MAP1LC3A', 'IFI16', 'IGFBP7', 'HRAS', 'SLC39A3', 'GABARAPL2', 'GABARAPL1', 'JUN', 'SERPINB2', 'IGFBP5', 'CDKN2A', 'IGFBP3', 'HMGA1', 'IGF1', 'COL3A1', 'FKBP8', 'IRF7', 'CD44']",0.8561328152141099,0,0,25
61,Vitamin A and carotenoid metabolism WP716,0.09477839845110421,1.6874554808072815,3.976005823478212,"['ADH4', 'CYP26A1', 'ALDH1A3', 'CYP26B1', 'RBP4', 'RBP2', 'NPC1L1', 'ALDH1A2', 'ALDH1A1', 'LPL', 'BCO1', 'RPE65']",0.8561328152141099,0,0,12
62,Pregnane X receptor pathway WP2876,0.09498535783611496,1.9681793027116767,4.633158098144752,"['SLCO1B1', 'HSP90AA1', 'CYP2A6', 'ABCB1', 'ABCC2', 'CYP2C19', 'CYP3A5', 'CYP3A7']",0.8561328152141099,0,0,8
63,Mitochondrial CIV Assembly WP4922,0.09651201894382054,1.7894895801872546,4.18398362995507,"['COX8A', 'COA3', 'PET100', 'NDUFA4', 'SCO2', 'COX4I1', 'COX14', 'HIGD1A', 'COX7C', 'COX6B1']",0.8561328152141099,0,0,10
64,IL-18 signaling pathway WP4754,0.0987175621110224,1.239432896792022,2.8698974703272224,"['MTCH1', 'CD83', 'CD81', 'HSPB1', 'TNFAIP3', 'ENO1', 'RND2', 'CXCL2', 'PTMS', 'CXCL16', 'FAM110A', 'CASP8', 'FAM186B', 'STMN1', 'BSG', 'NPPA', 'TGM2', 'TICAM2', 'USP5', 'IMP3', 'ARG1', 'IL18', 'TNFRSF1A', 'ARL4D', 'ACTA1', 'ARF6', 'MYH7', 'CEBPB', 'NRN1', 'STOML1', 'MEPCE', 'TNFRSF11B', 'GATA1', 'FUT1', 'CENPB', 'CCNB2', 'SOCS3', 'SPP1', 'HMOX1', 'MAPK3', 'SLC12A3', 'JUN', 'BAD', 'EEF2', 'VEGFA', 'NFKBIA', 'NR4A1', 'COL3A1', 'CYCS', 'PTPN7', 'NFKBIE', 'NOX1', 'IL18R1', 'CDK5R2', 'ITM2C']",0.8561328152141099,0,0,55
65,Metabolism of alpha-linolenic acid WP4586,0.10225842906394272,3.934512296214424,8.971679735581583,"['ALOX5', 'ALOX15', 'ALOX12']",0.8561328152141099,0,0,3
66,Robo4 and VEGF Signaling Pathways Crosstalk WP3943,0.10225842906394272,3.934512296214424,8.971679735581583,"['ROBO4', 'RAC1', 'VEGFA']",0.8561328152141099,0,0,3
67,Farnesoid X receptor pathway WP2879,0.1038751182310343,2.4595659386231685,5.569849122914485,"['SLC10A1', 'SLCO2B1', 'ABCB11', 'IP6K3', 'FKBP5']",0.8561328152141099,0,0,5
68,Osteoclast Signaling WP12,0.1038751182310343,2.4595659386231685,5.569849122914485,"['ATP6V1G1', 'GPR68', 'TRPV5', 'SPP1', 'TNFRSF11B']",0.8561328152141099,0,0,5
69,Calcium Regulation in the Cardiac Cell WP536,0.10474861851744789,1.3016675450400896,2.9368117828645266,"['RGS18', 'GNAZ', 'CHRM1', 'RGS14', 'YWHAB', 'ADCY4', 'ADRA1D', 'RGS4', 'GJA1', 'RGS2', 'GNG3', 'PLN', 'RGS1', 'GJA4', 'GJA9', 'YWHAG', 'YWHAH', 'PRKCH', 'ATP1B1', 'GNG11', 'GNG13', 'GJD2', 'FKBP1A', 'SLC8A3', 'GJB2', 'PRKAR1A', 'GJB3', 'GNB2', 'GJB5', 'GNAS', 'CASQ2', 'CALM3', 'CALR', 'CASQ1', 'CALM1', 'CALM2']",0.8561328152141099,0,0,36
70,Synaptic Vesicle Pathway WP2267,0.10522507037111908,1.5750554323725054,3.5464793850097305,"['NSF', 'RAB3A', 'SLC32A1', 'SYN3', 'SYN1', 'SLC6A4', 'STX1B', 'AP2S1', 'SLC17A6', 'SLC17A7', 'SLC25A4', 'SLC18A2', 'AP2M1', 'VAMP2']",0.8561328152141099,0,0,14
71,"COVID-19, thrombosis and anticoagulation WP4927",0.1066411050529856,7.867955801104972,17.61073721207275,"['F13A1', 'PLG']",0.8561328152141099,0,0,2
72,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.10931219805900524,1.4877423331792263,3.293188007430254,"['FZD1', 'JUN', 'CDKN1B', 'FZD2', 'FZD7', 'FZD9', 'WNT16', 'ELK1', 'SOD1', 'PPP2CA', 'ACTA1', 'NEFL', 'PFN4', 'NEFM', 'PFN1', 'NEFH', 'PFN2']",0.8653882346337916,0,0,17
73,Extracellular vesicles in the crosstalk of cardiac cells WP4300,0.11130572838512602,2.1466713596138374,4.712962345949723,"['CD81', 'SPP1', 'HSPB1', 'IGF1', 'ETS2', 'SOD1']",0.8690995230071484,0,0,6
74,Differentiation of white and brown adipocyte WP2895,0.11480123725369111,1.9679114799446749,4.259648732448388,"['PLAC8', 'CEBPA', 'CEBPB', 'LEP', 'HSPB7', 'ZIC1', 'EBF3']",0.8724894031280523,0,0,7
75,Globo Sphingolipid Metabolism WP1424,0.11480123725369111,1.9679114799446749,4.259648732448388,"['ST6GALNAC1', 'ST6GAL2', 'ST6GALNAC2', 'FUT2', 'A4GALT', 'FUT1', 'ABO']",0.8724894031280523,0,0,7
76,Trans-sulfuration pathway WP2333,0.12571585796390397,2.623180394324673,5.439770539322538,"['MPST', 'AHCY', 'GOT1', 'MAT2B']",0.9428689347292798,0,0,4
77,Metabolic reprogramming in colon cancer WP4290,0.1274008426449615,1.5747368421052632,3.244614436695389,"['HK3', 'LDHA', 'PKM', 'SHMT2', 'MDH2', 'PGAM1', 'FASN', 'PGK1', 'SLC1A5', 'ENO1', 'ALDOB', 'GAPDH']",0.9430971468523123,0,0,12
78,Differentiation Pathway WP2848,0.13088175909083524,1.603792937218581,3.2612503349503554,"['TPO', 'CSF1', 'HGF', 'FST', 'WNT5A', 'IGF1', 'FGF2', 'DKK1', 'NODAL', 'VEGFA', 'FGF10']",0.9564436241253345,0,0,11
79,Toll-like Receptor Signaling related to MyD88 WP3858,0.13699427293323155,1.6868846625281722,3.353216587902565,"['TLR1', 'TICAM2', 'TOLLIP', 'IRF7', 'TLR9', 'TLR6', 'TLR5', 'RELB', 'TLR2']",0.9798670610244894,0,0,9
80,15q13.3 copy number variation syndrome WP4942,0.13964463055042758,1.9676438053097345,3.873610707098849,"['TRPM1', 'GOLGA8R', 'GRM6', 'GOLGA8H', 'SERPINH1', 'CHRFAM7A']",0.9798670610244894,0,0,6
81,Apoptosis Modulation by HSP70 WP384,0.13964463055042758,1.9676438053097345,3.873610707098849,"['CASP7', 'CASP8', 'CASP6', 'CYCS', 'TNFRSF1A', 'HSPA1A']",0.9798670610244894,0,0,6
82,Exercise-induced Circadian Regulation WP410,0.14096333158597918,1.505256466676446,2.949181984301183,"['HSPA8', 'CEBPB', 'BTG1', 'GSTP1', 'G0S2', 'TOB1', 'HERPUD1', 'PER2', 'DNAJA1', 'CLDN5', 'TUBB3', 'SUMO3', 'EIF4G2']",0.9798670610244894,0,0,13
83,Codeine and Morphine Metabolism WP1604,0.1527636815322076,2.9506769825918764,5.54391815220952,"['SLCO1B1', 'ABCB1', 'ABCC2']",0.9964806297931587,0,0,3
84,MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma WP3593,0.1527636815322076,2.9506769825918764,5.54391815220952,"['HEY1', 'HES1', 'VEGFA']",0.9964806297931587,0,0,3
85,Nanomaterial-induced inflammasome activation WP3890,0.1527636815322076,2.9506769825918764,5.54391815220952,"['CASP1', 'NOX1', 'CTSB']",0.9964806297931587,0,0,3
86,Folate Metabolism WP176,0.15344013454985037,1.4504026140739876,2.7186996247434023,"['SERPINA3', 'GPX2', 'AHCY', 'CSF1', 'GPX4', 'GPX3', 'SHMT2', 'SAA4', 'PLG', 'SOD3', 'SOD1', 'RFK', 'ALB', 'SAA2']",0.9964806297931587,0,0,14
87,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.15547357366653958,1.5744186046511628,2.9304330828151137,"['LDHA', 'ANGPT2', 'PKM', 'BCL2A1', 'IGFBP3', 'BNIP3', 'IGFBP2', 'PGK1', 'PMAIP1', 'VEGFA']",0.9964806297931587,0,0,10
88,Heart Development WP1591,0.16017210584941005,1.6100948594721083,2.9488990080095663,"['FOXC1', 'HEY1', 'BHLHE40', 'SMYD1', 'NFATC2', 'NFATC1', 'VEGFA', 'TBX2', 'FGF10']",0.9964806297931587,0,0,9
89,Eicosanoid metabolism via lipooxygenases (LOX) WP4721,0.1645575533374953,1.6570646316954534,2.990164679604475,"['GGT5', 'CYSLTR2', 'TRPA1', 'ALOX5', 'ALOX15', 'CYP4A22', 'CYP4A11', 'ALOX12']",0.9964806297931587,0,0,8
90,Photodynamic therapy-induced NF-kB survival signaling WP3617,0.1645575533374953,1.6570646316954534,2.990164679604475,"['EGLN2', 'BCL2A1', 'CXCL2', 'SELE', 'BCL2L2', 'RELB', 'VEGFA', 'TNFRSF1A']",0.9964806297931587,0,0,8
91,Striated Muscle Contraction Pathway WP383,0.1645575533374953,1.6570646316954534,2.990164679604475,"['MYOM1', 'ACTA1', 'ACTC1', 'MYH3', 'ACTN3', 'TCAP', 'VIM', 'ACTG1']",0.9964806297931587,0,0,8
92,Classical pathway of steroidogenesis with glucocorticoid and mineralocorticoid metabolism WP4523,0.16722869818078867,2.248282397536129,4.0208123966082825,"['HSD11B1', 'HSD11B2', 'CYP21A2', 'HSD3B1']",0.9964806297931587,0,0,4
93,Serotonin Receptor 4/6/7 and NR3C Signaling WP734,0.1709325223819438,1.8161589516678012,3.208220099820189,"['EGR1', 'HTR7', 'RPS6KA5', 'GNAS', 'ELK1', 'MAPK3']",0.9964806297931587,0,0,6
94,ERK Pathway in Huntington's Disease WP3853,0.17132473985917465,1.9673762786839923,3.4708343314262664,"['CASP7', 'RPS6KA5', 'BDNF', 'ELK1', 'HRAS']",0.9964806297931587,0,0,5
95,Galanin receptor pathway WP4970,0.17132473985917465,1.9673762786839923,3.4708343314262664,"['CDKN1C', 'YAP1', 'CDKN1B', 'VAMP2', 'VEGFA']",0.9964806297931587,0,0,5
96,Major receptors targeted by epinephrine and norepinephrine WP4589,0.17132473985917465,1.9673762786839923,3.4708343314262664,"['ADCY10', 'ADCY4', 'ADRA1D', 'ADRA2C', 'ADRA2A']",0.9964806297931587,0,0,5
97,Mitochondrial complex III assembly WP4921,0.17132473985917465,1.9673762786839923,3.4708343314262664,"['UQCC3', 'UQCRFS1', 'UQCR11', 'UQCR10', 'UQCRH']",0.9964806297931587,0,0,5
98,Selective expression of chemokine receptors during T-cell polarization WP4494,0.17132473985917465,1.9673762786839923,3.4708343314262664,"['CCR1', 'IL4R', 'IL5', 'CXCR4', 'IL18R1']",0.9964806297931587,0,0,5
99,Tryptophan metabolism WP465,0.1783798799818876,1.5137575602691882,2.6094755989203122,"['TPH1', 'AANAT', 'HAAO', 'KYNU', 'ALDH1A2', 'ASMT', 'ALDH1A1', 'DHCR24', 'CYP2C18', 'ACMSD']",0.9999956783504922,0,0,10
100,Electron Transport Chain (OXPHOS system in mitochondria) WP111,0.17929619889787926,1.2929104477611941,2.2221460001924647,"['COX8A', 'NDUFB10', 'NDUFA4', 'COX4I1', 'NDUFA3', 'NDUFA1', 'ATP5MC3', 'NDUFC2', 'UQCR11', 'UQCR10', 'COX7C', 'ATP5F1D', 'UQCRH', 'COX6B1', 'ATP5MC1', 'ATP5F1B', 'NDUFS5', 'UQCRFS1', 'SLC25A5', 'SLC25A4', 'ATP5MF', 'SLC25A6']",0.9999956783504922,0,0,22
101,Secretion of Hydrochloric Acid in Parietal Cells WP2597,0.18502739396352888,3.9337016574585637,6.637143586982359,"['CHRM1', 'CCKBR']",0.9999956783504922,0,0,2
102,Pre-implantation embryo WP3527,0.19435794208545865,1.443109018739038,2.3638901508574692,"['EGR1', 'ZFP36', 'ARGFX', 'DLX2', 'FOXD1', 'SIX3', 'HMGA1', 'ATP1A1', 'GATA2', 'AQP3', 'TBX3']",0.9999956783504922,0,0,11
103,T-Cell Receptor and Co-stimulatory Signaling WP2583,0.19852504792018463,1.620291270034985,2.6197517383716518,"['NFKBIA', 'ZAP70', 'GSK3A', 'CD8B', 'NFATC2', 'CALM1', 'CALM2']",0.9999956783504922,0,0,7
104,Imatinib and Chronic Myeloid Leukemia WP3640,0.20479040406138974,1.686314791403287,2.674104442363024,"['SPRED2', 'ABCB1', 'CDKN1B', 'FLT1', 'PIM1', 'ABCG2']",0.9999956783504922,0,0,6
105,Lung fibrosis WP3624,0.2085180681942555,1.3890826136548802,2.177705907340932,"['MT2A', 'CEBPB', 'SERPINA1', 'CYSLTR2', 'IL5', 'TERT', 'HGF', 'SPP1', 'HMOX1', 'IGF1', 'CXCL2', 'FGF2']",0.9999956783504922,0,0,12
106,Dual hijack model of Vif in HIV infection WP3300,0.20914110294450078,2.3603757944183474,3.693388868682331,"['UBB', 'ELOB', 'RUNX1']",0.9999956783504922,0,0,3
107,Eicosanoid metabolism via cytochrome P450 monooxygenases (CYP) pathway WP4720,0.20914110294450078,2.3603757944183474,3.693388868682331,"['CYP4A11', 'CYP4A22', 'CYP2C18']",0.9999956783504922,0,0,3
108,NAD Biosynthesis II (from tryptophan) WP2485,0.20914110294450078,2.3603757944183474,3.693388868682331,"['KYNU', 'HAAO', 'KMO']",0.9999956783504922,0,0,3
109,Dopaminergic Neurogenesis WP2855,0.21000919715899707,1.7883982205242919,2.7909813328969544,"['CDKN1C', 'NEUROD1', 'ALDH1A1', 'SLC18A2', 'GLI2']",0.9999956783504922,0,0,5
110,Glutathione metabolism WP100,0.21000919715899707,1.7883982205242919,2.7909813328969544,"['GGT5', 'GPX2', 'GPX4', 'GPX3', 'GGT2']",0.9999956783504922,0,0,5
111,Regulation of Wnt/B-catenin Signaling by Small Molecule Compounds WP3664,0.21000919715899707,1.7883982205242919,2.7909813328969544,"['FZD1', 'SFRP4', 'FZD7', 'LEF1', 'DKK3']",0.9999956783504922,0,0,5
112,The influence of laminopathies on Wnt signaling WP4844,0.21156695489708302,1.4757127041239966,2.292097276341974,"['CEBPA', 'CEBPB', 'ICMT', 'CEBPD', 'LEF1', 'SPP1', 'HMGA2', 'HES1', 'HES5']",0.9999956783504922,0,0,9
113,Genes targeted by miRNAs in adipocytes WP1992,0.21274128479966148,1.9671088999447208,3.044452106126787,"['KCNE1', 'GJA1', 'IGF1', 'ERG']",0.9999956783504922,0,0,4
114,Pathogenesis of SARS-CoV-2 Mediated by nsp9-nsp10 Complex WP4884,0.21274128479966148,1.9671088999447208,3.044452106126787,"['ZAP70', 'MMP25', 'CD8B', 'HLA-DRA']",0.9999956783504922,0,0,4
115,Oxidation by Cytochrome P450 WP43,0.21811691371260658,1.3964588488578804,2.1264214858852557,"['CYP39A1', 'CYP26A1', 'CYP26B1', 'CYP2A6', 'CYP4A22', 'CYP4A11', 'CYP2C19', 'CYP4F11', 'CYP3A5', 'CYP2C18', 'CYP3A7']",0.9999956783504922,0,0,11
116,White fat cell differentiation WP4149,0.22086977973847263,1.4990381321316573,2.263820379098673,"['CEBPA', 'CEBPB', 'CEBPD', 'MECOM', 'EBF1', 'NR2F2', 'GATA2', 'KLF15']",0.9999956783504922,0,0,8
117,Oxidative phosphorylation WP623,0.22117871774453532,1.3464292485161367,2.031471212516347,"['NDUFA11', 'ATP6AP1', 'NDUFB10', 'NDUFA4', 'NDUFA3', 'ATP6AP2', 'NDUFC2', 'ATP5MC3', 'ATP5F1D', 'ATP5MC1', 'ATP5F1B', 'NDUFS5', 'ATP5MF']",0.9999956783504922,0,0,13
118,Regulation of toll-like receptor signaling pathway WP1449,0.22633069350263263,1.2079845745353395,1.7947728706682324,"['CD86', 'CD80', 'PELI3', 'LY96', 'TNFAIP3', 'CASP8', 'TIFA', 'SPP1', 'MAP3K8', 'CD14', 'RAC1', 'MAPK3', 'JUN', 'TICAM2', 'CISH', 'CD180', 'SFTPD', 'IRAK3', 'SMAD6', 'NFKBIA', 'TLR1', 'TOLLIP', 'IRF7', 'TLR9', 'TLR6', 'TLR5', 'TLR2']",0.9999956783504922,0,0,27
119,Amyotrophic lateral sclerosis (ALS) WP2447,0.23944270486111754,1.4165845557708276,2.0249242124006237,"['DAXX', 'BAD', 'CASP1', 'NEFL', 'NEFM', 'RAC1', 'NEFH', 'SOD1', 'TNFRSF1A']",0.9999956783504922,0,0,9
120,IL1 and megakaryocytes in obesity WP2865,0.24078607140332875,1.5737831858407079,2.2408255396394274,"['TLR1', 'IL1R1', 'IL18', 'TIMP2', 'S100A9', 'TLR2']",0.9999956783504922,0,0,6
121,Matrix Metalloproteinases WP129,0.24078607140332875,1.5737831858407079,2.2408255396394274,"['MMP25', 'MMP15', 'BSG', 'TIMP2', 'MMP19', 'MMP21']",0.9999956783504922,0,0,6
122,Pathways in clear cell renal cell carcinoma WP4018,0.24633719350370098,1.2300458078845087,1.7233605701789614,"['FLT1', 'TPI1', 'PKLR', 'SHMT2', 'EFCAB3', 'BHLHE41', 'ENO1', 'ENO2', 'VEGFA', 'LDHC', 'HK3', 'LDHA', 'PKM', 'FASN', 'PGK1', 'ALDOC', 'ALDOB', 'ALDOA', 'GAPDH', 'BAP1']",0.9999956783504922,0,0,20
123,Amplification and Expansion of Oncogenic Pathways as Metastatic Traits WP3678,0.2511356425892131,1.6392498387245416,2.2650532620362824,"['LEF1', 'TNC', 'CXCR4', 'CYTIP', 'VEGFA']",0.9999956783504922,0,0,5
124,GABA receptor Signaling WP4159,0.2513699634334056,1.4307994164109272,1.9756899957727485,"['GABRQ', 'GABRA1', 'SLC32A1', 'GAD1', 'AP2S1', 'GABRE', 'GABRD', 'AP2M1']",0.9999956783504922,0,0,8
125,Ganglio Sphingolipid Metabolism WP1423,0.2611262473225568,1.7484184018180702,2.3476910511970477,"['B3GALT1', 'B4GALNT1', 'FUT1', 'A3GALT2']",0.9999956783504922,0,0,4
126,SARS-CoV-2 and angiotensin-converting enzyme 2 receptor: molecular mechanisms WP4883,0.26835856715280865,2.6222836095764275,3.4494338210170024,"['MAS1', 'REN']",0.9999956783504922,0,0,2
127,Genes controlling nephrogenesis WP4823,0.26850894090229144,1.3620047265217483,1.7908606068463153,"['FOXC1', 'FOXD1', 'NPHS1', 'LAMB2', 'ITGA8', 'CXCR4', 'ETV4', 'PAX2', 'VEGFA']",0.9999956783504922,0,0,9
128,Folate-Alcohol and Cancer Pathway Hypotheses WP1589,0.26907580227991745,1.9668416689693284,2.5819952906198966,"['CEBPB', 'ALDH1L1', 'ALDH1A1']",0.9999956783504922,0,0,3
129,Apoptosis WP254,0.2690909178098914,1.2214015079030962,1.6033410537084345,"['HRK', 'JUN', 'CDKN2A', 'BAD', 'IGF1', 'TNFRSF1B', 'TNFRSF1A', 'NFKBIA', 'CASP7', 'CASP8', 'CASP6', 'CASP4', 'CASP1', 'IRF7', 'PMAIP1', 'CYCS', 'NFKBIE', 'BCL2L2']",0.9999956783504922,0,0,18
130,Toll-like Receptor Signaling Pathway WP75,0.27651727578605184,1.2060737915536337,1.5503861252700537,"['CD86', 'JUN', 'TICAM2', 'CD80', 'LY96', 'NFKBIA', 'TLR1', 'CASP8', 'TOLLIP', 'IRF7', 'TLR9', 'SPP1', 'MAP3K8', 'CD14', 'RAC1', 'TLR6', 'TLR5', 'TLR2', 'MAPK3']",0.9999956783504922,0,0,19
131,Endochondral Ossification with Skeletal Dysplasias WP4808,0.27735639071321316,1.2520913122354365,1.6057469959070352,"['CDKN1C', 'PTH', 'IGF1', 'FGF2', 'RUNX3', 'VEGFA', 'ACAN', 'SCIN', 'SERPINH1', 'SPP1', 'SOX9', 'CALM1', 'SLC38A2', 'CALM2']",0.9999956783504922,0,0,14
132,Endochondral Ossification WP474,0.27735639071321316,1.2520913122354365,1.6057469959070352,"['CDKN1C', 'PTH', 'IGF1', 'FGF2', 'RUNX3', 'VEGFA', 'ACAN', 'SCIN', 'SERPINH1', 'SPP1', 'SOX9', 'CALM1', 'SLC38A2', 'CALM2']",0.9999956783504922,0,0,14
133,Regulation of apoptosis by parathyroid hormone-related protein WP3872,0.2784560217640728,1.4753180309734513,1.88618693722271,"['GSK3A', 'BCL2L10', 'BCL2A1', 'ITGB4', 'BCL2L14', 'BCL2L2']",0.9999956783504922,0,0,6
134,Fas ligand pathway and stress induction of heat shock proteins WP314,0.282999786748318,1.3115540789959395,1.6555866948039888,"['ACTA1', 'CASP7', 'DAXX', 'JUN', 'CASP8', 'CASP6', 'HSPB1', 'CYCS', 'ACTB', 'ACTG1']",0.9999956783504922,0,0,10
135,Aryl Hydrocarbon Receptor Pathway WP2873,0.2830909547210764,1.368494502057217,1.7270223234455597,"['HSP90AA1', 'JUN', 'CDKN1B', 'SERPINB2', 'JUND', 'MYOF', 'AIP', 'HES1']",0.9999956783504922,0,0,8
136,ncRNAs involved in Wnt signaling in hepatocellular carcinoma WP4336,0.2891515986085765,1.2006151357249009,1.4897282618641567,"['FZD1', 'JUN', 'FZD2', 'FZD7', 'WNT5A', 'LEF1', 'FZD9', 'WNT7A', 'WNT16', 'DKK1', 'CXXC4', 'SFRP4', 'WNT6', 'FRAT1', 'FRAT2', 'SFRP2', 'CSNK2B', 'NOTUM']",0.9999956783504922,0,0,18
137,Nanomaterial induced apoptosis WP2507,0.2940167969921369,1.5130473618170606,1.8521490863929624,"['CASP7', 'ENDOG', 'CASP8', 'CASP6', 'CYCS']",0.9999956783504922,0,0,5
138,Intracellular trafficking proteins involved in CMT neuropathy WP4856,0.29923095378070824,1.3769571230982018,1.661353273226765,"['RAB3B', 'RAB3A', 'RAB25', 'HSPB1', 'NEFL', 'RABAC1', 'RAB11B']",0.9999956783504922,0,0,7
139,Monoamine Transport WP727,0.29923095378070824,1.3769571230982018,1.661353273226765,"['HRH3', 'ADORA2A', 'IL1R1', 'TGFB1I1', 'TNFRSF11B', 'SYN1', 'SLC6A4']",0.9999956783504922,0,0,7
140,Cells and molecules involved in local acute inflammatory response  WP4493,0.3112781836355991,1.5734660033167496,1.8363422707352024,"['SELP', 'C6', 'C7', 'ITGB2']",0.9999956783504922,0,0,4
141,Cysteine and methionine catabolism WP4504,0.3112781836355991,1.5734660033167496,1.8363422707352024,"['MPST', 'AHCY', 'GOT1', 'SQOR']",0.9999956783504922,0,0,4
142,Phytochemical activity on NRF2 transcriptional activation WP3,0.3112781836355991,1.5734660033167496,1.8363422707352024,"['CEBPB', 'KEAP1', 'HMOX1', 'SLC7A11']",0.9999956783504922,0,0,4
143,Vitamin B12 metabolism WP1533,0.3115939263934845,1.2691565748580003,1.4799056805566826,"['SERPINA3', 'SHMT2', 'TCN1', 'SAA4', 'ALB', 'SAA2', 'PLG', 'APOE', 'SOD3', 'SOD1']",0.9999956783504922,0,0,10
144,Prader-Willi and Angelman Syndrome WP3998,0.3160228946691919,1.2178548338149335,1.40289644811481,"['PCSK1', 'MAGEL2', 'CDKN2C', 'DLX5', 'CDKN2A', 'BDNF', 'ATP10A', 'TYR', 'GABRR2', 'NDN', 'GHRL', 'CGA', 'GABRD']",0.9999956783504922,0,0,13
145,TNF-alpha signaling pathway WP231,0.32228569967671,1.1573635561942712,1.3105022686950332,"['HSP90AA1', 'JUN', 'BAD', 'TNFAIP3', 'CYBA', 'TNFRSF1B', 'SELE', 'TNFRSF1A', 'PPP2CA', 'NFKBIA', 'CASP7', 'CASP8', 'RFK', 'MAP3K8', 'RAC1', 'NFKBIE', 'HRAS', 'NOX1', 'SKP1', 'MAPK3']",0.9999956783504922,0,0,20
146,Dopamine metabolism WP2436,0.33051576828929796,1.6857458650771722,1.866290781967318,"['PPP2CA', 'TYR', 'SOD1']",0.9999956783504922,0,0,3
147,Tamoxifen metabolism WP691,0.33051576828929796,1.6857458650771722,1.866290781967318,"['CYP2A6', 'CYP2C19', 'CYP3A5']",0.9999956783504922,0,0,3
148,Translation Factors WP107,0.3325940392772237,1.210568932452589,1.3326337865258293,"['EIF4A2', 'EIF5A', 'EEF1G', 'EEF1A1', 'EIF1AX', 'EIF3I', 'EEF1A2', 'EIF4H', 'EIF3G', 'EEF2', 'GSPT2', 'EIF1']",0.9999956783504922,0,0,12
149,Kynurenine Pathway and links to Cellular Senescence WP5044,0.33797545840549886,1.4048738101820768,1.5239818136938283,"['IL1R2', 'HAAO', 'KYNU', 'KMO', 'ACMSD']",0.9999956783504922,0,0,5
150,Arachidonate Epoxygenase / Epoxide Hydrolase WP678,0.3514086183560592,1.9665745856353591,2.056654670735614,"['COX8A', 'GSTP1']",0.9999956783504922,0,0,2
151,Composition of Lipid Particles WP3601,0.3514086183560592,1.9665745856353591,2.056654670735614,"['LPL', 'APOE']",0.9999956783504922,0,0,2
152,LncRNA-mediated mechanisms of therapeutic resistance WP3672,0.3514086183560592,1.9665745856353591,2.056654670735614,"['WNT6', 'ABCB1']",0.9999956783504922,0,0,2
153,mir-124 predicted interactions with cell cycle and differentiation  WP3595,0.3514086183560592,1.9665745856353591,2.056654670735614,"['SIX4', 'STRADB']",0.9999956783504922,0,0,2
154,Unfolded protein response WP4925,0.35692557078485815,1.3112094395280236,1.3508446838879717,"['PPP1R15A', 'XBP1', 'CASP8', 'HSPA5', 'PMAIP1', 'TXNIP']",0.9999956783504922,0,0,6
155,Ferroptosis WP4313,0.36068163697049466,1.2208499957051644,1.2449735054696713,"['PRNP', 'MAP1LC3B', 'MAP1LC3A', 'GPX4', 'PCBP1', 'ALOX15', 'HMOX1', 'SLC7A11', 'CP']",0.9999956783504922,0,0,9
156,Oxidative Stress WP408,0.37134587185102125,1.2516031686156168,1.239864860018149,"['GPX3', 'HMOX1', 'MT1X', 'XDH', 'SOD3', 'NOX1', 'SOD1']",0.9999956783504922,0,0,7
157,TGF-beta Receptor Signaling WP560,0.3788514579505384,1.1695120764630595,1.1351413822447798,"['TGFBR3', 'FKBP1A', 'JUN', 'FST', 'LEF1', 'SPP1', 'SMAD6', 'HRAS', 'RUNX3', 'TGFBR2', 'MAPK3']",0.9999956783504922,0,0,11
158,CAMKK2  Pathway WP4874,0.3828437157195653,1.2103358733131837,1.1620778770109588,"['MAP1LC3A', 'WFS1', 'HMOX1', 'NFATC2', 'RAC1', 'CALM1', 'CALM2', 'MAPK3']",0.9999956783504922,0,0,8
159,Wnt signaling in kidney disease WP4150,0.3828437157195653,1.2103358733131837,1.1620778770109588,"['FZD1', 'WNT6', 'FZD2', 'FZD7', 'WNT5A', 'FZD9', 'WNT7A', 'WNT16']",0.9999956783504922,0,0,8
160,The Overlap Between Signal Transduction Pathways that Contribute to a Range of LMNA Laminopathies WP4879,0.3861951886137973,1.1513546382001216,1.0954130419794301,"['CEBPA', 'CEBPB', 'ICMT', 'MSTN', 'CEBPD', 'LEF1', 'SPP1', 'HMGA2', 'TNFRSF11B', 'HES1', 'ACTB', 'HES5']",0.9999956783504922,0,0,12
161,22q11.2 copy number variation syndrome WP4657,0.39119458810572444,1.095590717299578,1.0282668594528943,"['TSKS', 'RTN4R', 'FOXC1', 'OAT', 'VWF', 'SERPIND1', 'LRRC74B', 'PAX3', 'ESS2', 'SLC7A4', 'CLDN5', 'CYP26A1', 'CYP26B1', 'MRPL40', 'RELN', 'ACTC1', 'THAP7', 'ALDH1A2', 'DGCR6L', 'HES1', 'RAN', 'FGF10']",0.9999956783504922,0,0,22
162,Osteoblast Signaling WP322,0.391748401681059,1.4749240121580547,1.3822036187057851,"['PTH', 'BGLAP', 'TNFRSF11B']",0.9999956783504922,0,0,3
163,Serotonin Transporter Activity WP1455,0.391748401681059,1.4749240121580547,1.3822036187057851,"['IL1R1', 'TGFB1I1', 'SLC6A4']",0.9999956783504922,0,0,3
164,MECP2 and Associated Rett Syndrome WP3584,0.40377270111179075,1.113322627385953,1.0096758315452943,"['CEBPD', 'DLX5', 'BDNF', 'GAD1', 'TAP1', 'IGF1', 'FGF2', 'POU3F2', 'GABRR2', 'CSRP1', 'BCL6', 'SST', 'GPRIN1', 'TET3', 'FKBP5']",0.9999956783504922,0,0,15
165,T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection WP3863,0.40725394292429207,1.1386552784620094,1.0228749306471012,"['NFKBIA', 'ZAP70', 'JUN', 'IL5', 'PTPRC', 'AHSA1', 'NFATC2', 'MAP3K8', 'CALM1', 'CALM2', 'MAPK3']",0.9999956783504922,0,0,11
166,Base Excision Repair WP4752,0.40786026803833625,1.1971014492753622,1.0735972631314317,"['FEN1', 'NEIL2', 'OGG1', 'TDG', 'POLD1', 'POLE3', 'POLE']",0.9999956783504922,0,0,7
167,Adipogenesis WP236,0.41730240762561616,1.0728687654757694,0.9376273511249179,"['FZD1', 'GDF10', 'WWTR1', 'CEBPA', 'CEBPB', 'CEBPD', 'EBF1', 'HMGA1', 'LPL', 'MIF', 'IGF1', 'GATA2', 'PRLR', 'KLF15', 'BSCL2', 'SFRP4', 'SOCS3', 'CYP26A1', 'CYP26B1', 'LEP', 'NDN', 'ID3', 'PLIN1', 'LPIN3']",0.9999956783504922,0,0,24
168,Common Pathways Underlying Drug Addiction WP2636,0.4240632189675934,1.1419247698722355,0.9796261238113606,"['PPP1CC', 'PPP1R1A', 'GNAS', 'DRD1', 'CALM1', 'CALM2', 'ACTB', 'ACTG1', 'MAPK3']",0.9999956783504922,0,0,9
169,Glycogen Synthesis and Degradation WP500,0.4240632189675934,1.1419247698722355,0.9796261238113606,"['PPP2CA', 'PTPA', 'HK3', 'GSK3A', 'PPP2R1A', 'HKDC1', 'CALM3', 'CALM1', 'CALM2']",0.9999956783504922,0,0,9
170,PI3K/AKT/mTOR - VitD3 signaling WP4141,0.426615572653742,1.2290917887752282,1.0470288428004413,"['CD86', 'HK3', 'LDHA', 'CD80', 'HLA-DRA']",0.9999956783504922,0,0,5
171,Urea cycle and metabolism of amino groups WP497,0.426615572653742,1.2290917887752282,1.0470288428004413,"['OAT', 'ARG1', 'ODC1', 'PYCR3', 'CKB']",0.9999956783504922,0,0,5
172,16p11.2 proximal deletion syndrome WP4949,0.42787551621714,1.0926285309429196,0.9275574637849192,"['IGFBP3', 'MVP', 'GDPD3', 'TBX6', 'SEZ6L2', 'SPN', 'PPP2CA', 'CASP8', 'PPP2R1A', 'TCP1', 'ALDOA', 'CCT7', 'CDIPT', 'YPEL3', 'MAPK3']",0.9999956783504922,0,0,15
173,LDLRAD4 and what we know about it WP4904,0.4308665625287374,1.5731491712707182,1.3245236996101946,"['NEDD4', 'TGFBR2']",0.9999956783504922,0,0,2
174,Role of Altered Glycolysation of MUC1 in Tumour Microenvironment WP4480,0.4308665625287374,1.5731491712707182,1.3245236996101946,"['NFKBIA', 'MUC1']",0.9999956783504922,0,0,2
175,Copper homeostasis WP3286,0.4357059332971094,1.1093808803584488,0.9216600211925415,"['PRNP', 'MT2A', 'JUN', 'MT1A', 'SCO2', 'MT1F', 'MT1G', 'MT1X', 'SOD3', 'MT1E', 'SOD1']",0.9999956783504922,0,0,11
176,Nuclear Receptors in Lipid Metabolism and Toxicity WP299,0.4365556364468326,1.1799225663716815,0.9779663726833472,"['CYP26A1', 'ABCB1', 'ABCC2', 'NR1I3', 'CYP4A11', 'ABCB11']",0.9999956783504922,0,0,6
177,Purinergic signaling WP4900,0.4365556364468326,1.1799225663716815,0.9779663726833472,"['GNAZ', 'ADORA2A', 'GNAT3', 'ADORA3', 'P2RY14', 'GNAS']",0.9999956783504922,0,0,6
178,LncRNA involvement in canonical Wnt signaling and colorectal cancer WP4258,0.43890037551174643,1.0727474523256988,0.8833891043909693,"['FZD1', 'JUN', 'FZD2', 'FZD7', 'WNT5A', 'LEF1', 'FZD9', 'WNT7A', 'WNT16', 'DKK1', 'CXXC4', 'SFRP4', 'WNT6', 'FRAT1', 'FRAT2', 'SFRP2', 'CSNK2B', 'NOTUM']",0.9999956783504922,0,0,18
179,Oncostatin M Signaling Pathway WP2374,0.444698904911779,1.0879126061913773,0.881598514014818,"['EGR1', 'CEBPB', 'CDKN1B', 'PRKCH', 'JUND', 'OSMR', 'VEGFA', 'NFKBIA', 'SOCS3', 'CASP7', 'CDK2', 'HRAS', 'MAPK3']",0.9999956783504922,0,0,13
180,Cardiac Progenitor Differentiation WP2406,0.45048315459443244,1.1237251956676417,0.8960973466581506,"['MESP1', 'ACTC1', 'CXCR4', 'THY1', 'IGF1', 'FGF2', 'DKK1', 'NODAL']",0.9999956783504922,0,0,8
181,Renin-angiotensin-aldosterone system (RAAS) WP4756,0.45048315459443244,1.1237251956676417,0.8960973466581506,"['CREB3', 'CYP21A2', 'CREB3L1', 'HSD3B1', 'CALM3', 'REN', 'CALM1', 'CALM2']",0.9999956783504922,0,0,8
182,ACE Inhibitor Pathway WP554,0.4514174163380373,1.3109514598876302,1.0426820662822116,"['MAS1', 'ATP6AP2', 'REN']",0.9999956783504922,0,0,3
183,Biomarkers for urea cycle disorders WP4583,0.4514174163380373,1.3109514598876302,1.0426820662822116,"['F10', 'GOT1', 'ARG1']",0.9999956783504922,0,0,3
184,Cancer immunotherapy by CTLA4 blockade WP4582,0.4514174163380373,1.3109514598876302,1.0426820662822116,"['CD86', 'PPP2CA', 'CD80']",0.9999956783504922,0,0,3
185,EDA signaling in hair follicle development WP3930,0.4514174163380373,1.3109514598876302,1.0426820662822116,"['SOSTDC1', 'DKK1', 'RELB']",0.9999956783504922,0,0,3
186,RalA downstream regulated genes WP2290,0.4514174163380373,1.3109514598876302,1.0426820662822116,"['RAC1', 'YBX3', 'HRAS']",0.9999956783504922,0,0,3
187,Sulfation Biotransformation Reaction WP692,0.4514174163380373,1.3109514598876302,1.0426820662822116,"['SULT1C2', 'SULT1B1', 'SULT4A1']",0.9999956783504922,0,0,3
188,FGF23 signaling in hypophosphatemic rickets and related disorders WP4790,0.46266146026606264,1.2101033295063146,0.9326988546227943,"['PTH', 'SPP1', 'ROS1', 'PHEX']",0.9999956783504922,0,0,4
189,miR-509-3p alteration of YAP1/ECM axis WP3967,0.46266146026606264,1.2101033295063146,0.9326988546227943,"['YAP1', 'COL3A1', 'TEAD2', 'TEAD3']",0.9999956783504922,0,0,4
190,nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell WP5027,0.46266146026606264,1.2101033295063146,0.9326988546227943,"['EIF1AX', 'EIF3I', 'EIF3G', 'EIF1']",0.9999956783504922,0,0,4
191,Nonalcoholic fatty liver disease WP4396,0.4650256437298708,1.0369354553045063,0.7939428285446591,"['CEBPA', 'GSK3A', 'NDUFA11', 'NDUFB10', 'NDUFB11', 'COX4I1', 'UQCR11', 'UQCR10', 'COX7C', 'UQCRH', 'SOCS3', 'CASP7', 'CASP8', 'LEPR', 'UQCRFS1', 'RAC1', 'COX8A', 'XBP1', 'JUN', 'PKLR', 'NDUFA4', 'NDUFA3', 'NDUFA1', 'NDUFC2', 'COX6B1', 'TNFRSF1A', 'NDUFS5', 'LEP', 'CYCS']",0.9999956783504922,0,0,29
192,"Oligodendrocyte specification and differentiation, leading to myelin components for CNS WP4304",0.4757912437771387,1.123656763590392,0.8346253711155636,"['CXCL1', 'SOX9', 'IGF1', 'CXCL2', 'FGF2', 'GLI2']",0.9999956783504922,0,0,6
193,VEGFA-VEGFR2 Signaling Pathway WP3888,0.4777631385161757,1.0131167484857053,0.7483287530858788,"['FLT1', 'ARPC5L', 'HSPB1', 'NRARP', 'ELK1', 'HERPUD1', 'ACTG1', 'RND1', 'TUBB8', 'CDH5', 'GJA1', 'RPS6KA5', 'CSRP1', 'RPL18A', 'CFL1', 'BSG', 'SH3BGRL3', 'CHAC1', 'RAC1', 'ATP6V1E1', 'IER5', 'TMSB10', 'ADAMTS9', 'CLIC1', 'HRAS', 'DUSP5', 'HSP90AA1', 'SSR4', 'IGFBP3', 'DKK1', 'EPN1', 'RCN1', 'TXNIP', 'ERG', 'PFN1', 'ATP6V0D1', 'ALDOA', 'DSC1', 'GAPDH', 'SLC25A11', 'FJX1', 'ARF6', 'EPHA2', 'LRRC59', 'SET', 'PBXIP1', 'CRIP2', 'FOXO4', 'GATA2', 'FUT1', 'APOLD1', 'PPP2CA', 'PRDX2', 'STIP1', 'SDCBP', 'LDHA', 'DNAJB4', 'AP2S1', 'PGK1', 'S1PR1', 'DNAJB9', 'IGFBP7', 'CCT7', 'ABCF2', 'SLC25A25', 'MAPK3', 'EGR1', 'JUN', 'EGR3', 'TNFRSF10C', 'NFATC2', 'NFATC1', 'SELE', 'VEGFA', 'DNAJA1', 'NFKBIA', 'NR4A1', 'NR4A3', 'ALB', 'CYCS', 'ACKR3', 'HYOU1', 'CALR', 'EIF4G2', 'HSPA1A']",0.9999956783504922,0,0,85
194,Hepatitis C and Hepatocellular Carcinoma WP3646,0.48702874053830864,1.072566238079662,0.7716386262720947,"['CASP7', 'JUN', 'RRM2', 'MYOF', 'LEF1', 'RAC1', 'CD44', 'MAPK3', 'VEGFA']",0.9999956783504922,0,0,9
195,NO/cGMP/PKG mediated Neuroprotection WP4008,0.48702874053830864,1.072566238079662,0.7716386262720947,"['NFKBIA', 'BAD', 'NPPA', 'CNGA1', 'NEFL', 'TSPO', 'CYCS', 'CALM1', 'CALM2']",0.9999956783504922,0,0,9
196,Netrin-UNC5B signaling pathway WP4747,0.48975907581666034,1.062898446619377,0.7587412242829535,"['YAP1', 'PTPA', 'CDH5', 'ROBO4', 'JUN', 'ITGB4', 'RAC1', 'NTN1', 'SELE', 'MAPK3']",0.9999956783504922,0,0,10
197,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.4921832962317949,1.0551161424103856,0.7479761367028095,"['TGFBR3', 'FKBP1A', 'JUN', 'FST', 'LEF1', 'SPP1', 'SMAD6', 'HRAS', 'RUNX3', 'TGFBR2', 'MAPK3']",0.9999956783504922,0,0,11
198,Nicotine Metabolism WP1600,0.4932909036227867,1.9663076498204917,1.389503513012232,['CYP2A6'],0.9999956783504922,0,0,1
199,ApoE and miR-146 in inflammation and atherosclerosis WP3926,0.504775009741786,1.310865561694291,0.8961633760011283,"['APOE', 'TLR2']",0.9999956783504922,0,0,2
200,Canonical NF-KB pathway WP4562,0.504775009741786,1.310865561694291,0.8961633760011283,"['NFKBIA', 'NFKBIE']",0.9999956783504922,0,0,2
201,BMP Signaling Pathway in Eyelid Development WP3927,0.5108456255836367,1.1235884071704967,0.7547006668868756,"['FOXC1', 'JUN', 'MAPK3', 'FGF10']",0.9999956783504922,0,0,4
202,Nicotine Activity on Dopaminergic Neurons WP1602,0.5108456255836367,1.1235884071704967,0.7547006668868756,"['CHRNB2', 'CDK5', 'DRD3', 'SLC18A2']",0.9999956783504922,0,0,4
203,Proteoglycan biosynthesis WP4784,0.5108456255836367,1.1235884071704967,0.7547006668868756,"['XYLT1', 'B3GALT6', 'B4GALT7', 'CHST3']",0.9999956783504922,0,0,4
204,Hypothesized Pathways in Pathogenesis of Cardiovascular Disease WP3668,0.5126547739561054,1.0923724387921236,0.7298715021868307,"['TGFBR3', 'FBN3', 'ANGPT2', 'MAPK3', 'TGFBR2']",0.9999956783504922,0,0,5
205,Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4) WP2817,0.5141822746482054,1.0725060337892196,0.7134068355849263,"['CEBPA', 'CEBPB', 'GJB2', 'GAL', 'PGR', 'PRLR']",0.9999956783504922,0,0,6
206,Alpha 6 Beta 4 signaling pathway WP244,0.5155319947915349,1.058750930950101,0.7014816885307452,"['LAMB3', 'ITGB4', 'LAMB2', 'LAMB1', 'RAC1', 'HRAS', 'MAPK3']",0.9999956783504922,0,0,7
207,Melatonin metabolism and effects WP3298,0.5155319947915349,1.058750930950101,0.7014816885307452,"['PER2', 'AANAT', 'ASMT', 'APOE', 'CYP2C19', 'CALM1', 'CALM2']",0.9999956783504922,0,0,7
208,Overview of leukocyte-intrinsic Hippo pathway functions WP4542,0.5155319947915349,1.058750930950101,0.7014816885307452,"['YAP1', 'FYB1', 'LPL', 'FOXO4', 'RAC1', 'TEAD2', 'TEAD3']",0.9999956783504922,0,0,7
209,Neural Crest Cell Migration during Development WP4564,0.5167569537120721,1.0486626083748385,0.6923088323655879,"['NGFR', 'ARF1', 'JUN', 'BDNF', 'CDH11', 'RAC1', 'F2RL2', 'EPHB3']",0.9999956783504922,0,0,8
210,Acute viral myocarditis WP4298,0.5467850609839544,0.9996804706479397,0.6035065956017521,"['ENDOG', 'CD80', 'ITGB2', 'CXCR4', 'NOD2', 'AIF1', 'ACTB', 'CASP7', 'CASP8', 'CASP6', 'CASP1', 'CYCS', 'TLR5', 'EIF4G2', 'MAPK3']",0.9999956783504922,0,0,15
211,Modulators of TCR signaling and T cell activation WP5072,0.5472197763447487,1.0058992870621422,0.6064614806691697,"['NFKBIA', 'ZAP70', 'FIBP', 'CDKN1B', 'NDUFB10', 'CD5', 'TNFAIP3', 'RHOH', 'ELOB', 'MAP3K8', 'ZFP36L1']",0.9999956783504922,0,0,11
212,Regulation of Microtubule Cytoskeleton WP2038,0.5481146294844966,1.011134395634811,0.6079656233892397,"['SPRED1', 'PARD6A', 'CFL2', 'STMN1', 'RHO', 'TPPP', 'RAC1', 'PHLDB2', 'F2RL2']",0.9999956783504922,0,0,9
213,TNF related weak inducer of apoptosis (TWEAK) Signaling Pathway WP2036,0.5488686789291322,1.0147633754038952,0.6087525574132171,"['NFKBIA', 'CASP7', 'JUN', 'CASP8', 'TNFSF12', 'RAC1', 'RELB', 'MAPK3']",0.9999956783504922,0,0,8
214,Eicosanoid metabolism via cyclooxygenases (COX) WP4719,0.5514439244699224,1.0258031935359753,0.6105735746946163,"['PRXL2B', 'CYP4A22', 'CYP4A11', 'TBXAS1', 'PTGDR', 'PTGES']",0.9999956783504922,0,0,6
215,Urea cycle and associated pathways WP4595,0.5536361198865661,1.0348063966939745,0.6118268309482765,"['SLC25A15', 'OAT', 'GOT1', 'MDH2', 'ARG1']",0.9999956783504922,0,0,5
216,Nucleotide metabolism WP404,0.5569443094229066,1.048608807812788,0.6137402775800549,"['PRPS1', 'RRM2', 'POLD1', 'OAZ1']",0.9999956783504922,0,0,4
217,Serotonin Receptor 2 and ELK-SRF/GATA4 signaling WP732,0.5569443094229066,1.048608807812788,0.6137402775800549,"['HTR2B', 'ELK1', 'HRAS', 'MAPK3']",0.9999956783504922,0,0,4
218,Transcription factor regulation in adipogenesis WP3599,0.5569443094229066,1.048608807812788,0.6137402775800549,"['CEBPA', 'CEBPB', 'CEBPD', 'LEP']",0.9999956783504922,0,0,4
219,Nephrogenesis WP5052,0.5622937640070951,1.072445929312467,0.6174402106427704,"['FOXD1', 'ALDH1A2', 'PAX2']",0.9999956783504922,0,0,3
220,Cytosine methylation WP3585,0.5721175949463086,1.1235201262825572,0.6273856862041526,"['TDG', 'TET3']",0.9999956783504922,0,0,2
221,Estrogen Receptor Pathway WP2881,0.5721175949463086,1.1235201262825572,0.6273856862041526,"['JUN', 'PDK4']",0.9999956783504922,0,0,2
222,FOXP3 in COVID-19 WP5063,0.5721175949463086,1.1235201262825572,0.6273856862041526,"['CD86', 'CD80']",0.9999956783504922,0,0,2
223,Leptin and adiponectin WP3934,0.5721175949463086,1.1235201262825572,0.6273856862041526,"['LEP', 'LEPR']",0.9999956783504922,0,0,2
224,Nucleotide GPCRs WP80,0.5721175949463086,1.1235201262825572,0.6273856862041526,"['ADORA2A', 'ADORA3']",0.9999956783504922,0,0,2
225,PTF1A related regulatory pathway WP4147,0.5721175949463086,1.1235201262825572,0.6273856862041526,"['HES1', 'FGF10']",0.9999956783504922,0,0,2
226,Somitogenesis in the context of spondylocostal dysostosis WP4785,0.5721175949463086,1.1235201262825572,0.6273856862041526,"['TBX6', 'DLL3']",0.9999956783504922,0,0,2
227,Supression of HMGB1 mediated inflammation by THBD WP4479,0.5721175949463086,1.1235201262825572,0.6273856862041526,"['NFKBIA', 'THBD']",0.9999956783504922,0,0,2
228,Urea cycle and related diseases WP4571,0.5721175949463086,1.1235201262825572,0.6273856862041526,"['SLC25A15', 'ARG1']",0.9999956783504922,0,0,2
229,IL-4 signaling pathway WP395,0.575553586407406,0.9829734219269103,0.543017070012916,"['NFKBIA', 'CEBPA', 'SOCS3', 'CEBPB', 'HRH1', 'IL4R', 'NFIL3', 'BAD', 'ELK1', 'MAPK3']",0.9999956783504922,0,0,10
230,Wnt signaling WP428,0.5860995506975347,0.9712890210235718,0.5189263330531304,"['FZD1', 'JUN', 'FZD2', 'FZD7', 'WNT5A', 'LEF1', 'FZD9', 'NFATC2', 'WNT7A', 'NFATC1', 'WNT16', 'DKK1', 'CXXC4', 'SFRP4', 'WNT6', 'FRAT1', 'FRAT2', 'SFRP2', 'CSNK2B', 'RAC1', 'NOTUM']",0.9999956783504922,0,0,21
231,Type I collagen synthesis in the context of Osteogenesis imperfecta WP4786,0.5873398164064377,0.9829922566371682,0.5231010231296134,"['FZD1', 'ADAMTS2', 'CREB3L1', 'SERPINH1', 'TNFRSF11B', 'SP7']",0.9999956783504922,0,0,6
232,Canonical and non-canonical Notch signaling WP3845,0.5928431360028262,0.9829969588056401,0.5139358185984624,"['HEY1', 'LEF1', 'HES1', 'DLL3', 'DLK2']",0.9999956783504922,0,0,5
233,Photodynamic therapy-induced unfolded protein response WP3613,0.5928431360028262,0.9829969588056401,0.5139358185984624,"['PPP1R15A', 'XBP1', 'HSPA5', 'DNAJB9', 'CALR']",0.9999956783504922,0,0,5
234,Aflatoxin B1 metabolism WP699,0.596045323253735,1.3107797109454111,0.6782479780111793,['EPHX1'],0.9999956783504922,0,0,1
235,Synthesis and Degradation of Ketone Bodies WP311,0.596045323253735,1.3107797109454111,0.6782479780111793,['BDH1'],0.9999956783504922,0,0,1
236,Vitamin B6-dependent and responsive disorders WP4228,0.596045323253735,1.3107797109454111,0.6782479780111793,['PNPO'],0.9999956783504922,0,0,1
237,3q29 copy number variation syndrome WP4906,0.5975156002199933,0.9628356605800215,0.4958361848929677,"['CASP7', 'TM4SF19', 'JUN', 'DYNLT3', 'MAD2L1BP', 'FBXO45', 'SLC51A', 'DYNLRB1', 'DYNLL1', 'SLC51B', 'DYNLL2', 'HAMP']",0.9999956783504922,0,0,12
238,Breast cancer pathway WP4262,0.5991946315514989,0.9655078151695321,0.4945029850521098,"['SHC3', 'LEF1', 'FGF2', 'DLL3', 'WNT6', 'FRAT1', 'FRAT2', 'HEY1', 'HES1', 'HRAS', 'HES5', 'SKP1', 'MAPK3', 'FZD1', 'JUN', 'FZD2', 'FZD7', 'WNT5A', 'FZD9', 'WNT7A', 'IGF1', 'WNT16', 'FGF17', 'SFRP4', 'RAD51', 'CSNK2B', 'PGR', 'FGF10']",0.9999956783504922,0,0,28
239,STING pathway in Kawasaki-like disease and COVID-19 WP4961,0.600587740470366,0.9830016583747927,0.5011799901868991,"['GSDMD', 'NFKBIA', 'FCGR2A', 'NFKBIE']",0.9999956783504922,0,0,4
240,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.6027467147654005,0.9589309348242984,0.4854666608271053,"['BEX3', 'SOCS3', 'CASP7', 'CDKN1B', 'JUND', 'HSPA5', 'HSPB1', 'APOE', 'VIM', 'YBX3']",0.9999956783504922,0,0,10
241,IL-3 signaling pathway WP286,0.6061261661819817,0.956343833454268,0.4788099124070284,"['CD86', 'LYN', 'HCK', 'JUN', 'YWHAB', 'BAD', 'CSF2RB', 'HRAS', 'MAPK3']",0.9999956783504922,0,0,9
242,Neural Crest Cell Migration in Cancer WP4565,0.6102214807667845,0.9531284063658164,0.47078186335889416,"['NGFR', 'ARF1', 'JUN', 'BDNF', 'CDH11', 'RAC1', 'F2RL2', 'EPHB3']",0.9999956783504922,0,0,8
243,Corticotropin-releasing hormone signaling pathway WP2355,0.6120958743607107,0.9530244205784971,0.467807620016933,"['GNAZ', 'HSP90AA1', 'JUND', 'HSD3B1', 'IL18', 'ELK1', 'TBX19', 'NFKBIA', 'NR4A1', 'GJA1', 'TRIM28', 'CYP21A2', 'GNB2', 'CRH', 'GNAS', 'MAPK3']",0.9999956783504922,0,0,16
244,Biomarkers for pyrimidine metabolism disorders WP4584,0.6123245845044093,0.9830063553467808,0.4821575103851067,"['RRM2', 'CKB', 'UPB1']",0.9999956783504922,0,0,3
245,Leptin Insulin Overlap WP3935,0.6123245845044093,0.9830063553467808,0.4821575103851067,"['SOCS3', 'LEP', 'LEPR']",0.9999956783504922,0,0,3
246,Platelet-mediated interactions with vascular and circulating cells WP4462,0.6123245845044093,0.9830063553467808,0.4821575103851067,"['SELP', 'SELE', 'TLR2']",0.9999956783504922,0,0,3
247,Regulation of sister chromatid separation at the metaphase-anaphase transition WP4240,0.6123245845044093,0.9830063553467808,0.4821575103851067,"['PTTG1', 'BUB3', 'MAD2L1']",0.9999956783504922,0,0,3
248,Tryptophan catabolism leading to NAD+ production WP4210,0.6123245845044093,0.9830063553467808,0.4821575103851067,"['HAAO', 'KYNU', 'KMO']",0.9999956783504922,0,0,3
249,Fibrin Complement Receptor 3 Signaling Pathway WP4136,0.6216810352511389,0.9436061946902655,0.44852256121752515,"['TICAM2', 'TYROBP', 'ITGB2', 'LY96', 'PLG', 'CD14']",0.9999956783504922,0,0,6
250,Prion disease pathway WP3995,0.6216810352511389,0.9436061946902655,0.44852256121752515,"['PRNP', 'HSPA5', 'EBF1', 'ELK1', 'MAPK3', 'BATF']",0.9999956783504922,0,0,6
251,7-oxo-C and 7beta-HC pathways WP5064,0.6300544179829882,0.9361217530971471,0.43244058783114786,"['HSD11B1', 'HSD11B2', 'DBP', 'THEM5', 'ACOT6']",0.9999956783504922,0,0,5
252,Cannabinoid receptor signaling WP3869,0.6300544179829882,0.9361217530971471,0.43244058783114786,"['CNR2', 'ADORA2A', 'PRKAR1A', 'CYP2C19', 'MAPK3']",0.9999956783504922,0,0,5
253,Gene regulatory network modelling somitogenesis  WP2854,0.6325180016507298,0.9830110497237569,0.45026486680545114,"['HES1', 'TBX6']",0.9999956783504922,0,0,2
254,IL-10 Anti-inflammatory Signaling Pathway  WP4495,0.6325180016507298,0.9830110497237569,0.45026486680545114,"['IL10RA', 'HMOX1']",0.9999956783504922,0,0,2
255,Mammary gland development pathway - Involution (Stage 4 of 4) WP2815,0.6325180016507298,0.9830110497237569,0.45026486680545114,"['SOCS3', 'CHI3L1']",0.9999956783504922,0,0,2
256,Methionine metabolism leading to sulfur amino acids and related disorders WP4292,0.6325180016507298,0.9830110497237569,0.45026486680545114,"['AHCY', 'MAT2B']",0.9999956783504922,0,0,2
257,Nanoparticle triggered regulated necrosis WP2513,0.6325180016507298,0.9830110497237569,0.45026486680545114,"['CASP8', 'TNFRSF1A']",0.9999956783504922,0,0,2
258,SRF and miRs in Smooth Muscle Differentiation and Proliferation WP1991,0.6325180016507298,0.9830110497237569,0.45026486680545114,"['MYOCD', 'ELK1']",0.9999956783504922,0,0,2
259,Alzheimer's disease WP2059,0.6354645257364133,0.9359446578742392,0.4243563821739522,"['PSENEN', 'BAD', 'LPL', 'TNFRSF1A', 'CASP7', 'CASP8', 'CDK5', 'CYCS', 'CALM3', 'APOE', 'CALM1', 'GAPDH', 'CALM2', 'MAPK3', 'CDK5R1']",0.9999956783504922,0,0,15
260,Interactions between immune cells and microRNAs in tumor microenvironment WP4559,0.6415223357932601,0.9251129971059734,0.4106680923405953,"['CD86', 'IL4R', 'CD80', 'TGFBR2']",0.9999956783504922,0,0,4
261,mBDNF and proBDNF regulation of GABA neurotransmission WP4829,0.6459346658325132,0.9173259566620563,0.4009236543159821,"['GABRQ', 'NGFR', 'GABRA1', 'SLC12A5', 'BDNF', 'GABRE', 'GABRD']",0.9999956783504922,0,0,7
262,Fluoropyrimidine Activity WP1601,0.6543238470297786,0.9072498298162015,0.3848126201586877,"['CDA', 'CYP2A6', 'RRM2', 'TDG', 'UPB1', 'ABCG2']",0.9999956783504922,0,0,6
263,Mammalian disorder of sexual development WP4842,0.6583477496566884,0.9073267158373541,0.37928252145954117,"['FST', 'SOX9', 'INSL3']",0.9999956783504922,0,0,3
264,MAPK pathway in congenital thyroid cancer WP4928,0.6583477496566884,0.9073267158373541,0.37928252145954117,"['JUN', 'ELK1', 'MAPK3']",0.9999956783504922,0,0,3
265,Small Ligand GPCRs WP247,0.6583477496566884,0.9073267158373541,0.37928252145954117,"['CNR2', 'S1PR1', 'PTGDR']",0.9999956783504922,0,0,3
266,Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms WP4534,0.6669382254349148,0.8985374337892323,0.3639596436768587,"['ACTA1', 'ACTC1', 'ITGB4', 'ITGB2', 'ACTB', 'TEAD2', 'ACTG1', 'TEAD3']",0.9999956783504922,0,0,8
267,G13 Signaling Pathway WP524,0.6751038029910107,0.8876723330210146,0.3487565334469084,"['CFL2', 'CFL1', 'ARHGDIG', 'RAC1', 'PFN1', 'CALM1', 'CALM2']",0.9999956783504922,0,0,7
268,Amino Acid Metabolism Pathway Excerpt (Histidine catabolism extension) WP4661,0.6779669293166396,0.9830157415078707,0.38205572202021565,['UROC1'],0.9999956783504922,0,0,1
269,Benzene metabolism WP3891,0.6779669293166396,0.9830157415078707,0.38205572202021565,['EPHX1'],0.9999956783504922,0,0,1
270,miR-517 relationship with ARCN1 and USP1 WP3596,0.6779669293166396,0.9830157415078707,0.38205572202021565,['ID2'],0.9999956783504922,0,0,1
271,SARS-CoV-2 altering angiogenesis via NRP1 WP5065,0.6779669293166396,0.9830157415078707,0.38205572202021565,['VEGFA'],0.9999956783504922,0,0,1
272,Steroid Biosynthesis WP496,0.6779669293166396,0.9830157415078707,0.38205572202021565,['HSD3B1'],0.9999956783504922,0,0,1
273,TCA Cycle Nutrient Utilization and Invasiveness of Ovarian Cancer WP2868,0.6779669293166396,0.9830157415078707,0.38205572202021565,['MAPK3'],0.9999956783504922,0,0,1
274,"GPCRs, Class B Secretin-like WP334",0.679595733093014,0.8736564093114674,0.33745605025650227,"['ADGRE1', 'ADGRE2', 'ADGRG2', 'GIPR']",0.9999956783504922,0,0,4
275,NRF2-ARE regulation WP4357,0.679595733093014,0.8736564093114674,0.33745605025650227,"['CEBPB', 'KEAP1', 'HMOX1', 'SLC7A11']",0.9999956783504922,0,0,4
276,Wnt signaling pathway and pluripotency WP399,0.6846094235658873,0.90694100572014,0.34364610330337025,"['FZD1', 'JUN', 'PRKCH', 'FZD2', 'FZD7', 'WNT5A', 'ESRRB', 'LEF1', 'FZD9', 'WNT7A', 'ZBTB33', 'WNT16', 'PPP2CA', 'PTPA', 'WNT6', 'FRAT1', 'PPP2R1A', 'CD44']",0.9999956783504922,0,0,18
277,SARS-CoV-2 innate immunity evasion and cell-specific immune response WP5039,0.6854963776142878,0.8844312205923056,0.33397189893118356,"['LAG3', 'CASP8', 'CD160', 'BSG', 'CXCL17', 'IRF7', 'CXCL1', 'CXCL2', 'CXCL5']",0.9999956783504922,0,0,9
278,Structural Pathway of Interleukin 1 (IL-1) WP2637,0.6854963776142878,0.8844312205923056,0.33397189893118356,"['NFKBIA', 'RPS6KA5', 'IL1R1', 'TOLLIP', 'MKNK2', 'IRF7', 'MAP3K8', 'ELK1', 'MAPK3']",0.9999956783504922,0,0,9
279,Alanine and aspartate metabolism WP106,0.6860223040566401,0.8737262124002455,0.32925947559530394,"['GOT1', 'GAD1']",0.9999956783504922,0,0,2
280,Neuroinflammation WP4919,0.6860223040566401,0.8737262124002455,0.32925947559530394,"['NFKBIA', 'JUN']",0.9999956783504922,0,0,2
281,Role of Osx and miRNAs in tooth development WP3971,0.6860223040566401,0.8737262124002455,0.32925947559530394,"['SP7', 'DKK1']",0.9999956783504922,0,0,2
282,ATM Signaling Network in Development and Disease  WP3878,0.6933434466934814,0.873516571358298,0.319907806636263,"['PTPA', 'TRIM28', 'ATMIN', 'CDK5', 'CHEK2', 'H2AFX', 'HSPB1', 'CDK5R1']",0.9999956783504922,0,0,8
283,Prostaglandin Synthesis and Regulation WP98,0.6933434466934814,0.873516571358298,0.319907806636263,"['HSD11B1', 'HSD11B2', 'ANXA3', 'TBXAS1', 'S100A6', 'SOX9', 'PTGDR', 'PTGES']",0.9999956783504922,0,0,8
284,16p11.2 distal deletion syndrome WP4950,0.6979254589111927,0.8545996562128115,0.30735076220751567,"['CR2', 'PLN', 'CD81', 'NFATC2', 'TUFM']",0.9999956783504922,0,0,5
285,Ethanol effects on histone modifications WP3996,0.6979254589111927,0.8545996562128115,0.30735076220751567,"['ALDH1A3', 'AHCY', 'ADH1B', 'ALDH1A2', 'ALDH1A1']",0.9999956783504922,0,0,5
286,Extracellular vesicle-mediated signaling in recipient cells WP2870,0.6979254589111927,0.8545996562128115,0.30735076220751567,"['TGFBR3', 'HGF', 'WNT5A', 'HRAS', 'TGFBR2']",0.9999956783504922,0,0,5
287,Signal transduction through IL1R WP4496,0.6979254589111927,0.8545996562128115,0.30735076220751567,"['NFKBIA', 'JUN', 'IL1R1', 'TOLLIP', 'IRAK3']",0.9999956783504922,0,0,5
288,FOXA2 pathway WP5066,0.7002804835977023,0.8424584534007027,0.30014632385199497,"['SLCO1B1', 'ABCC2', 'FASN']",0.9999956783504922,0,0,3
289,TGF-B Signaling in Thyroid Cells for Epithelial-Mesenchymal Transition WP3859,0.7002804835977023,0.8424584534007027,0.30014632385199497,"['TNC', 'VIM', 'MAPK3']",0.9999956783504922,0,0,3
290,Cytosolic DNA-sensing pathway WP4655,0.702134335959884,0.8734465362372339,0.30887736284416817,"['NFKBIA', 'CASP8', 'POLR1C', 'CASP1', 'IL18', 'IRF7', 'POLR2E', 'POLR3K', 'POLR2K', 'POLR2L']",0.9999956783504922,0,0,10
291,IL-5 signaling pathway WP127,0.7027177116649064,0.8598720608575381,0.3033628767795564,"['LYN', 'GSK3A', 'SPRED1', 'JUN', 'CSF2RB', 'ELK1', 'MAPK3']",0.9999956783504922,0,0,7
292,p38 MAPK Signaling Pathway WP400,0.7141451006191114,0.8423277496839444,0.28358573813870447,"['DAXX', 'RPS6KA5', 'HSPB1', 'RAC1', 'ELK1', 'HRAS']",0.9999956783504922,0,0,6
293,Parkinson's disease pathway WP2371,0.7141451006191114,0.8423277496839444,0.28358573813870447,"['CASP7', 'PINK1', 'UBB', 'CASP6', 'CYCS', 'UBE2L6']",0.9999956783504922,0,0,6
294,DNA Mismatch Repair WP531,0.7147411621672912,0.8276163044426987,0.2779423666601211,"['POLD1', 'RPA3', 'POLE3', 'POLE']",0.9999956783504922,0,0,4
295,IL-7 signaling pathway WP205,0.7147411621672912,0.8276163044426987,0.2779423666601211,"['CDKN1B', 'BAD', 'IL7', 'MAPK3']",0.9999956783504922,0,0,4
296,NAD Metabolism in Oncogene-Induced Senescence and Mitochondrial Dysfunction-Associated Senescence WP5046,0.7147411621672912,0.8276163044426987,0.2779423666601211,"['GOT1', 'MDH2', 'SCO2', 'HMGA1']",0.9999956783504922,0,0,4
297,Statin inhibition of cholesterol production WP430,0.7147411621672912,0.8276163044426987,0.2779423666601211,"['APOC2', 'APOC1', 'LPL', 'APOE']",0.9999956783504922,0,0,4
298,7q11.23 copy number variation syndrome WP4932,0.7192439429540217,0.8841426193118757,0.29137335382731155,"['CDKN1C', 'PKLR', 'H2AFX', 'FZD9', 'HMGA1', 'ATP5MC3', 'VPS37D', 'UBE2L6', 'ATP5F1D', 'ATP5MC1', 'CLDN5', 'ATP5F1B', 'CFL1', 'BCL7B', 'EIF4H', 'GAPDH', 'VAMP2', 'MAPK3']",0.9999956783504922,0,0,18
299,BMP2-WNT4-FOXO1 pathway in primary endometrial stromal cell differentiation WP3876,0.7329432259424394,0.7862983425414365,0.2442927002537919,"['SST', 'DKK1']",0.9999956783504922,0,0,2
300,Bone morphogenic protein (BMP) signaling and regulation WP1425,0.7329432259424394,0.7862983425414365,0.2442927002537919,"['SMAD6', 'TOB1']",0.9999956783504922,0,0,2
301,Disorders of Folate Metabolism and Transport WP4259,0.7329432259424394,0.7862983425414365,0.2442927002537919,"['ALDH1L1', 'SHMT2']",0.9999956783504922,0,0,2
302,Iron metabolism in placenta WP2007,0.7329432259424394,0.7862983425414365,0.2442927002537919,"['HEPHL1', 'HAMP']",0.9999956783504922,0,0,2
303,LTF danger signal response pathway WP4478,0.7329432259424394,0.7862983425414365,0.2442927002537919,"['CD14', 'TLR2']",0.9999956783504922,0,0,2
304,Mammary gland development pathway - Puberty (Stage 2 of 4) WP2814,0.7329432259424394,0.7862983425414365,0.2442927002537919,"['PGR', 'VIM']",0.9999956783504922,0,0,2
305,MFAP5-mediated ovarian cancer cell motility and invasiveness WP3301,0.7329432259424394,0.7862983425414365,0.2442927002537919,"['JUN', 'MAPK3']",0.9999956783504922,0,0,2
306,Purine metabolism WP4792,0.7329432259424394,0.7862983425414365,0.2442927002537919,"['PRPS1', 'XDH']",0.9999956783504922,0,0,2
307,TCA Cycle (aka Krebs or citric acid cycle) WP78,0.7381674111486665,0.7862392926222713,0.23869016924897468,"['MDH2', 'IDH3G', 'IDH3B']",0.9999956783504922,0,0,3
308,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.742007497064473,0.8274255089855241,0.24690040591871548,"['PPP1R15A', 'PPP1CC', 'XBP1', 'MAP1LC3A', 'HSPA5', 'PPP1R1A', 'PPP1R3A', 'PPP1R9B']",0.9999956783504922,0,0,8
309,Effects of nitric oxide WP1995,0.7432785081969191,0.7863573598453466,0.23330001001353853,['XDH'],0.9999956783504922,0,0,1
310,"Gamma-glutamyl cycle for the biosynthesis and degradation of glutathione, including diseases WP4518",0.7432785081969191,0.7863573598453466,0.23330001001353853,['GGT2'],0.9999956783504922,0,0,1
311,Hfe effect on hepcidin production WP3924,0.7432785081969191,0.7863573598453466,0.23330001001353853,['HAMP'],0.9999956783504922,0,0,1
312,let-7 inhibition of ES cell reprogramming WP3299,0.7432785081969191,0.7863573598453466,0.23330001001353853,['EGR1'],0.9999956783504922,0,0,1
313,miRNA Biogenesis WP2338,0.7432785081969191,0.7863573598453466,0.23330001001353853,['RAN'],0.9999956783504922,0,0,1
314,Somatic sex determination WP4814,0.7432785081969191,0.7863573598453466,0.23330001001353853,['SOX9'],0.9999956783504922,0,0,1
315,Angiogenesis WP1539,0.7469621331735292,0.7861802100608071,0.22936083320982276,"['FLT1', 'TIMP2', 'FGF2', 'VEGFA']",0.9999956783504922,0,0,4
316,Follicle Stimulating Hormone (FSH) signaling pathway WP2035,0.7469621331735292,0.7861802100608071,0.22936083320982276,"['BDNF', 'FSHR', 'CGA', 'MAPK3']",0.9999956783504922,0,0,4
317,miRNA regulation of p53 pathway in prostate cancer WP3982,0.7469621331735292,0.7861802100608071,0.22936083320982276,"['CASP8', 'EI24', 'CHEK2', 'PMAIP1']",0.9999956783504922,0,0,4
318,Physiological and pathological hypertrophy of the heart WP1528,0.7469621331735292,0.7861802100608071,0.22936083320982276,"['JUN', 'RAC1', 'CALM1', 'CALM2']",0.9999956783504922,0,0,4
319,"Relationship between inflammation, COX-2 and EGFR WP4483",0.7469621331735292,0.7861802100608071,0.22936083320982276,"['PTGES2', 'HRAS', 'MAPK3', 'PLA1A']",0.9999956783504922,0,0,4
320,Aryl Hydrocarbon Receptor Netpath WP2586,0.7531334432958441,0.8091774469123749,0.2294122052228326,"['HSP90AA1', 'CDKN1B', 'CDK2', 'AIP', 'LPL', 'HRAS', 'VEGFA']",0.9999956783504922,0,0,7
321,DNA Replication WP466,0.7531334432958441,0.8091774469123749,0.2294122052228326,"['POLD1', 'RPA3', 'GMNN', 'UBC', 'CDK2', 'POLE', 'UBA52']",0.9999956783504922,0,0,7
322,IL-6 signaling pathway WP364,0.7531334432958441,0.8091774469123749,0.2294122052228326,"['SOCS3', 'HCK', 'BAD', 'RAC1', 'VIP', 'MAPK3', 'NR2F6']",0.9999956783504922,0,0,7
323,Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway WP2203,0.7531334432958441,0.8091774469123749,0.2294122052228326,"['LYN', 'NFKBIA', 'HCK', 'CISH', 'RELB', 'MAPK3', 'CRLF2']",0.9999956783504922,0,0,7
324,Cardiac Hypertrophic Response WP2795,0.7541886053792521,0.8225529258041053,0.23205271109793382,"['NPPA', 'NFATC2', 'RAC1', 'IGF1', 'CALM1', 'FGF2', 'CALM2', 'TNFRSF1A', 'MAPK3']",0.9999956783504922,0,0,9
325,Phosphodiesterases in neuronal function WP4222,0.7541886053792521,0.8225529258041053,0.23205271109793382,"['ADCY10', 'PDE10A', 'ADORA2A', 'ADCY4', 'PDE5A', 'PDE6B', 'CHRFAM7A', 'PDE6A', 'DRD1']",0.9999956783504922,0,0,9
326,Endothelin Pathways WP2197,0.7566628999096374,0.7861210948299696,0.21919998990203537,"['ADCY10', 'GNAS', 'CALM1', 'CALM2', 'GNG13']",0.9999956783504922,0,0,5
327,Type II interferon signaling (IFNG) WP619,0.7566628999096374,0.7861210948299696,0.21919998990203537,"['SOCS3', 'TAP1', 'IRF8', 'GBP1', 'PSMB9']",0.9999956783504922,0,0,5
328,Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling WP3850,0.7664198645955975,0.7860619469026549,0.20911223420988193,"['MAP1LC3A', 'MSTN', 'IGFBP5', 'TNFSF9', 'IGF1', 'TNFRSF1A']",0.9999956783504922,0,0,6
329,Nuclear receptors WP170,0.7664198645955975,0.7860619469026549,0.20911223420988193,"['NR4A1', 'NR1I3', 'ESRRB', 'PGR', 'NR2F2', 'NR2F6']",0.9999956783504922,0,0,6
330,Hereditary leiomyomatosis and renal cell carcinoma pathway WP4206,0.7721466971417341,0.737047526941144,0.19058628373215486,"['LDHA', 'KEAP1', 'VEGFA']",0.9999956783504922,0,0,3
331,Host-pathogen interaction of human coronaviruses - apoptosis WP4864,0.7721466971417341,0.737047526941144,0.19058628373215486,"['CASP7', 'CASP8', 'BAD']",0.9999956783504922,0,0,3
332,Amino Acid metabolism WP3925,0.772216497507591,0.8334341194651615,0.2154346614793516,"['MPST', 'AOC3', 'TPH1', 'OAT', 'GOT1', 'ARG1', 'MDH2', 'ODC1', 'ADH4', 'TPO', 'LDHA', 'PKM', 'ALDH1A1', 'PDK4']",0.9999956783504922,0,0,14
333,Cell-type Dependent Selectivity of CCK2R Signaling WP3679,0.773750166366151,0.7147664490205927,0.1833420542953799,"['CCKBR', 'CCK']",0.9999956783504922,0,0,2
334,Homologous recombination WP186,0.773750166366151,0.7147664490205927,0.1833420542953799,"['RAD51', 'POLD1']",0.9999956783504922,0,0,2
335,Osteopontin Signaling WP1434,0.773750166366151,0.7147664490205927,0.1833420542953799,"['SPP1', 'MAPK3']",0.9999956783504922,0,0,2
336,Prolactin Signaling Pathway WP2037,0.7786140649620014,0.8238364661822147,0.2061566556769604,"['JUN', 'CISH', 'ELK1', 'PRLR', 'NFKBIA', 'ZAP70', 'SOCS3', 'RAC1', 'CTSD', 'HRAS', 'PPIA', 'YWHAG', 'MAPK3']",0.9999956783504922,0,0,13
337,Ebola Virus Pathway on Host WP4217,0.7817505926655137,0.8504081054231786,0.20938707936339285,"['VPS18', 'CD300A', 'VPS4A', 'ICAM2', 'ACTB', 'ACTG1', 'HLA-E', 'RHOB', 'RELB', 'BST2', 'SOCS3', 'SCIN', 'C1QBP', 'NEDD4', 'IRF7', 'HLA-DRA', 'RAC1', 'CLEC4G', 'CTSB', 'HLA-DQB1', 'MAPK3']",0.9999956783504922,0,0,21
338,Proteasome Degradation WP183,0.7842939507077187,0.8019187741541799,0.19484332064746257,"['PSMD8', 'PSMD10', 'PSMB6', 'UBB', 'H2AFZ', 'NEDD4', 'H2AFX', 'UBC', 'HLA-E', 'PSMB9']",0.9999956783504922,0,0,10
339,Vitamin D-sensitive calcium signaling in depression WP4698,0.7897395501319444,0.760651584356266,0.17955338199135384,"['TPH1', 'CHRM1', 'CALB1', 'GPX4', 'PVALB', 'GGT2']",0.9999956783504922,0,0,6
340,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.7934046597551283,0.8003733448208663,0.18522391838439048,"['EGR1', 'JUN', 'CDKN1B', 'PAX8', 'KCNIP3', 'CDK2', 'GNAS', 'CGA', 'HRAS', 'MYL12B', 'MAPK3']",0.9999956783504922,0,0,11
341,Activation of NLRP3 Inflammasome by SARS-CoV-2 WP4876,0.7953470822462592,0.6552517720703305,0.15003737412706433,['CASP1'],0.9999956783504922,0,0,1
342,Benzo(a)pyrene metabolism WP696,0.7953470822462592,0.6552517720703305,0.15003737412706433,['EPHX1'],0.9999956783504922,0,0,1
343,"Cerebral organic acidurias, including diseases WP4519",0.7953470822462592,0.6552517720703305,0.15003737412706433,['MDH2'],0.9999956783504922,0,0,1
344,Cholesterol Biosynthesis with Skeletal Dysplasias WP4804,0.7953470822462592,0.6552517720703305,0.15003737412706433,['DHCR24'],0.9999956783504922,0,0,1
345,COVID-19 adverse outcome pathway WP4891,0.7953470822462592,0.6552517720703305,0.15003737412706433,['IL7'],0.9999956783504922,0,0,1
346,Glial Cell Differentiation WP2276,0.7953470822462592,0.6552517720703305,0.15003737412706433,['TPPP'],0.9999956783504922,0,0,1
347,Molybdenum cofactor (Moco) biosynthesis WP4507,0.7953470822462592,0.6552517720703305,0.15003737412706433,['XDH'],0.9999956783504922,0,0,1
348,Peroxiredoxin 2 induced ovarian failure WP4873,0.7953470822462592,0.6552517720703305,0.15003737412706433,['PRDX2'],0.9999956783504922,0,0,1
349,Metabolism of Spingolipids in ER and Golgi apparatus WP4142,0.8024217604664707,0.6936430278107375,0.15268534384488677,"['B3GALT1', 'B4GALNT1', 'SGMS2']",0.9999956783504922,0,0,3
350,Methionine De Novo and Salvage Pathway WP3580,0.8024217604664707,0.6936430278107375,0.15268534384488677,"['AHCY', 'ODC1', 'MAT2B']",0.9999956783504922,0,0,3
351,Triacylglyceride synthesis WP325,0.8024217604664707,0.6936430278107375,0.15268534384488677,"['GPD1', 'LPL', 'AGPAT1']",0.9999956783504922,0,0,3
352,Initiation of transcription and translation elongation at the HIV-1 LTR WP3414,0.8063795990825965,0.727787505503845,0.15662036661976947,"['HEXIM1', 'NFKBIA', 'SUPT4H1', 'NFATC2', 'NFATC1']",0.9999956783504922,0,0,5
353,H19 action Rb-E2F1 signaling and CDK-Beta-catenin activity WP3969,0.8089928414790698,0.6551565377532228,0.13887039347931215,"['TULP3', 'PMAIP1']",0.9999956783504922,0,0,2
354,Hedgehog Signaling Pathway Netpath WP47,0.8089928414790698,0.6551565377532228,0.13887039347931215,"['SAP18', 'GLI2']",0.9999956783504922,0,0,2
355,"Metabolic pathway of LDL, HDL and TG, including diseases WP4522",0.8089928414790698,0.6551565377532228,0.13887039347931215,"['LPL', 'APOE']",0.9999956783504922,0,0,2
356,Riboflavin and CoQ disorders WP5037,0.8089928414790698,0.6551565377532228,0.13887039347931215,"['RFK', 'SLC52A1']",0.9999956783504922,0,0,2
357,Primary focal segmental glomerulosclerosis (FSGS) WP2572,0.8099013097472165,0.7857657158681806,0.16567310540503122,"['CDKN1C', 'CDKN1B', 'CR1', 'KIRREL2', 'NPHS1', 'ITGB4', 'LAMB2', 'CD80', 'VIM', 'DKK1', 'PAX2']",0.9999956783504922,0,0,11
358,IL-2 signaling pathway WP49,0.8112337218351272,0.7368293694690266,0.1541440237781165,"['SOCS3', 'JUN', 'CISH', 'NMI', 'HRAS', 'MAPK3']",0.9999956783504922,0,0,6
359,Mitochondrial complex I assembly model OXPHOS system WP4324,0.8225256544051439,0.7484122592036261,0.14622149872681228,"['NDUFB10', 'NDUFB11', 'NDUFS5', 'NDUFA3', 'NDUFA1', 'NDUFC2', 'NDUFAF3', 'TMEM70']",0.9999956783504922,0,0,8
360,Intraflagellar transport proteins binding to dynein WP4532,0.8268761492163835,0.6834907587665537,0.1299318353907012,"['DYNLT3', 'DYNLRB1', 'DYNLL1', 'DYNLL2']",0.9999956783504922,0,0,4
361,MAPK Cascade WP422,0.8280247685150156,0.7017457245546822,0.1324279875063354,"['JUN', 'ELK1', 'HRAS', 'SIPA1', 'MAPK3']",0.9999956783504922,0,0,5
362,PDGF Pathway WP2526,0.8309638741208751,0.7144509251810137,0.1322941332510137,"['NFKBIA', 'JUN', 'RAC1', 'ELK1', 'HRAS', 'MAPK3']",0.9999956783504922,0,0,6
363,G1 to S cell cycle control WP45,0.834206173523266,0.7554945054945055,0.13695203735359915,"['CDKN1C', 'CDKN2D', 'CREB3', 'CDKN1B', 'CDKN2C', 'CDKN2A', 'CREB3L1', 'RPA3', 'CDK2', 'POLE']",0.9999956783504922,0,0,10
364,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.8357105389695856,0.8248587174653014,0.14803984476606238,"['RAB3A', 'SHC3', 'KCNA3', 'ELK1', 'PPP2CA', 'RPS6KA5', 'CFL1', 'IGF2BP1', 'SPP1', 'RAC1', 'HRAS', 'MAPK3', 'NSF', 'NTRK1', 'NGFR', 'EGR1', 'JUN', 'BDNF', 'BAD', 'EEF2', 'SYN1', 'NFKBIA', 'MARCKS', 'CDK5', 'CDK5R1']",0.9999956783504922,0,0,25
365,Caloric restriction and aging WP4191,0.8368572947063814,0.5616049236596047,0.10002280241382801,['IGF1'],0.9999956783504922,0,0,1
366,Hijack of ubiquitination by SARS-CoV-2 WP4860,0.8368572947063814,0.5616049236596047,0.10002280241382801,['ELOB'],0.9999956783504922,0,0,1
367,Ketogenesis and Ketolysis WP4742,0.8368572947063814,0.5616049236596047,0.10002280241382801,['BDH1'],0.9999956783504922,0,0,1
368,Liver X receptor pathway WP2874,0.8368572947063814,0.5616049236596047,0.10002280241382801,['FASN'],0.9999956783504922,0,0,1
369,Methylation Pathways WP704,0.8368572947063814,0.5616049236596047,0.10002280241382801,['MAT2B'],0.9999956783504922,0,0,1
370,Mitochondrial CII Assembly WP4920,0.8368572947063814,0.5616049236596047,0.10002280241382801,['SDHAF1'],0.9999956783504922,0,0,1
371,Serine Metabolism WP4688,0.8368572947063814,0.5616049236596047,0.10002280241382801,['SHMT2'],0.9999956783504922,0,0,1
372,Airway smooth muscle cell contraction WP4962,0.8392494370714556,0.6047173820654483,0.10597509685996724,"['CALM1', 'CALM2']",0.9999956783504922,0,0,2
373,MAP3K1 role in promoting and blocking gonadal determination WP4872,0.8392494370714556,0.6047173820654483,0.10597509685996724,"['FRAT1', 'SOX9']",0.9999956783504922,0,0,2
374,miRNAs involved in DNA damage response WP1545,0.8392494370714556,0.6047173820654483,0.10597509685996724,"['CDKN1B', 'H2AFX']",0.9999956783504922,0,0,2
375,Androgen receptor signaling pathway WP138,0.84407272193383,0.7744683176665313,0.13128525512416206,"['DAXX', 'JUN', 'TGFB1I1', 'LIMK2', 'RNF6', 'ETV5', 'RHOB', 'PRDX1', 'BMF', 'STUB1', 'RAC1', 'CALR', 'FKBP4', 'RAN']",0.9999956783504922,0,0,14
376,Signaling of Hepatocyte Growth Factor Receptor WP313,0.8476591586077712,0.6774999284985652,0.11197492505609108,"['JUN', 'HGF', 'ELK1', 'HRAS', 'MAPK3']",0.9999956783504922,0,0,5
377,IL17 signaling pathway WP2112,0.8483678904670922,0.6549659111848166,0.10770318663616384,"['CEBPB', 'CEBPD', 'IL17RB', 'MAPK3']",0.9999956783504922,0,0,4
378,One-carbon metabolism WP241,0.8483678904670922,0.6549659111848166,0.10770318663616384,"['ALDH1L1', 'AHCY', 'SHMT2', 'MAT2B']",0.9999956783504922,0,0,4
379,ATM Signaling Pathway WP2516,0.8490044328961704,0.6933888599687663,0.1135014266863527,"['NFKBIA', 'JUN', 'RAD51', 'CHEK2', 'H2AFX', 'CDK2']",0.9999956783504922,0,0,6
380,Nephrotic syndrome WP4758,0.8490044328961704,0.6933888599687663,0.1135014266863527,"['NPHS1', 'ITGB4', 'LAMB2', 'ARHGDIA', 'EMP2', 'PAX2']",0.9999956783504922,0,0,6
381,B Cell Receptor Signaling Pathway WP23,0.8497900815813345,0.775137524987962,0.12616597458537665,"['LYN', 'JUN', 'GSK3A', 'CR2', 'CD81', 'NFATC2', 'ELK1', 'ILF2', 'NFKBIA', 'PTPRC', 'BCL6', 'HCLS1', 'RAC1', 'PIK3AP1', 'HRAS']",0.9999956783504922,0,0,15
382,One-carbon metabolism and related pathways WP3940,0.8515259615032327,0.705188495229989,0.11334162554405507,"['GPX2', 'GPX4', 'GPX3', 'SHMT2', 'GAD1', 'SOD3', 'SOD1']",0.9999956783504922,0,0,7
383,Osteoblast differentiation WP4787,0.8553039208585015,0.7853496115427303,0.12274889574708049,"['FZD1', 'PRKCH', 'FZD2', 'FZD7', 'WNT5A', 'FZD9', 'WNT8B', 'WNT7A', 'WNT16', 'FGF2', 'GLI2', 'DLL3', 'WNT6', 'HEY1', 'SOX9', 'FGFR4', 'FGF10', 'MAPK3']",0.9999956783504922,0,0,18
384,Deregulation of Rab and Rab Effector Genes in Bladder Cancer WP2291,0.8650924757067497,0.561483820047356,0.0813696004062093,"['SYTL4', 'SYTL3']",0.9999956783504922,0,0,2
385,Glycosaminoglycan degradation WP4815,0.8650924757067497,0.561483820047356,0.0813696004062093,"['HYAL1', 'IDS']",0.9999956783504922,0,0,2
386,NOTCH1 regulation of endothelial cell calcification WP3413,0.8650924757067497,0.561483820047356,0.0813696004062093,"['VEGFA', 'DLL3']",0.9999956783504922,0,0,2
387,Serotonin and anxiety WP3947,0.8650924757067497,0.561483820047356,0.0813696004062093,"['GABRA1', 'CRH']",0.9999956783504922,0,0,2
388,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.8653973504647117,0.6548705188461893,0.0946723472626921,"['IFITM3', 'BST2', 'JUN', 'IFITM2', 'MAPK3']",0.9999956783504922,0,0,5
389,Development of ureteric collection system WP5053,0.8654394277777848,0.6735303413400758,0.09733718516318308,"['FOXC1', 'ITGA8', 'CELSR1', 'ETV4', 'PAX2', 'GLI2']",0.9999956783504922,0,0,6
390,Regulatory circuits of the STAT3 signaling pathway WP4538,0.8661388538368018,0.7322869386854667,0.10523698815656506,"['SOCS3', 'DUSP2', 'PTPRC', 'TRIM28', 'IL10RA', 'STMN1', 'IL21R', 'CSF2RB', 'OSMR', 'F2RL2', 'MAPK3']",0.9999956783504922,0,0,11
391,miRNAs involvement in the immune response in sepsis WP4329,0.8675559260393999,0.6287230514096186,0.08932601688918416,"['NFKBIA', 'IRF7', 'ELANE', 'RELB']",0.9999956783504922,0,0,4
392,PDGFR-beta pathway WP3972,0.8675559260393999,0.6287230514096186,0.08932601688918416,"['JUN', 'ELK1', 'HRAS', 'MAPK3']",0.9999956783504922,0,0,4
393,Sphingolipid pathway WP1422,0.8675559260393999,0.6287230514096186,0.08932601688918416,"['PPP2CA', 'ACER1', 'SERINC1', 'SGMS2']",0.9999956783504922,0,0,4
394,Type I interferon induction and signaling during SARS-CoV-2 infection WP4868,0.8675559260393999,0.6287230514096186,0.08932601688918416,"['IRF7', 'TLR9', 'TLR6', 'TLR2']",0.9999956783504922,0,0,4
395,RANKL/RANK signaling pathway WP2018,0.8689857819790798,0.6983705343417573,0.09807113720370256,"['LYN', 'NFKBIA', 'JUN', 'TNFRSF11B', 'NFATC1', 'RAC1', 'RELB', 'MAPK3']",0.9999956783504922,0,0,8
396,Aspirin and miRNAs WP4707,0.8699496739853833,0.49136978735156034,0.06845759700761547,['VEGFA'],0.9999956783504922,0,0,1
397,"Degradation pathway of sphingolipids, including diseases WP4153",0.8699496739853833,0.49136978735156034,0.06845759700761547,['NEU1'],0.9999956783504922,0,0,1
398,Interleukin-1 Induced Activation of NF-kappa-B WP3656,0.8699496739853833,0.49136978735156034,0.06845759700761547,['TIFA'],0.9999956783504922,0,0,1
399,Tgif disruption of Shh signaling WP3674,0.8699496739853833,0.49136978735156034,0.06845759700761547,['NODAL'],0.9999956783504922,0,0,1
400,Vitamin D Metabolism WP1531,0.8699496739853833,0.49136978735156034,0.06845759700761547,['PTH'],0.9999956783504922,0,0,1
401,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.87078071904027,0.8467014601680988,0.11715392503423869,"['CDKN1B', 'CHRM1', 'FLT1', 'HSP90AB1', 'CSF1', 'ITGB4', 'ITGB2', 'TNC', 'SLC2A2', 'HIF3A', 'FGF2', 'PPP2R1A', 'CREB3L1', 'PELO', 'HRAS', 'HSP90AA1', 'IL4R', 'VWF', 'HGF', 'OSMR', 'PRLR', 'CREB3', 'ITGA8', 'EPHA2', 'PFKFB1', 'EFNA4', 'PPP2CA', 'GNG3', 'RELN', 'SPP1', 'MAPK3', 'NGFR', 'ANGPT2', 'LAMB3', 'LAMB2', 'BAD', 'LAMB1', 'IGF1', 'GNG11', 'GNG13', 'RAB11B', 'VEGFA', 'EFNA1', 'FGF17', 'COL3A1', 'EFNA3', 'GNB2', 'FGFR4', 'FGF10']",0.9999956783504922,0,0,49
402,Estrogen signaling pathway WP712,0.8735846860471517,0.5894722298977618,0.07966729203640882,"['JUN', 'GNAS', 'ELK1']",0.9999956783504922,0,0,3
403,Pathways Regulating Hippo Signaling WP4540,0.8818773809131913,0.7455440019933112,0.09371656340639425,"['NTRK1', 'NGFR', 'PRKCH', 'FLT1', 'LEF1', 'CDH5', 'PRKAR1A', 'CDH11', 'GNAS', 'RAC1', 'FGFR4', 'CDH17', 'TEAD2', 'EPHA2', 'TEAD3']",0.9999956783504922,0,0,15
404,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.8840206183622613,0.7849916620344636,0.09676976288986036,"['FZD1', 'FZD2', 'GDF15', 'FZD7', 'WNT5A', 'EIF5A2', 'FZD9', 'WNT8B', 'WNT7A', 'CLDN2', 'WNT16', 'TGFBR2', 'DLL3', 'CLDN5', 'WNT6', 'CLDN10', 'CLDN20', 'CLDN9', 'MMP15', 'ID2', 'PKP1', 'CLDN18', 'HRAS', 'MAPK3']",0.9999956783504922,0,0,24
405,Pyrimidine metabolism WP4022,0.8845695246891386,0.7292720579503622,0.08944825539276342,"['CDA', 'RRM2', 'UPB1', 'DCK', 'POLD1', 'POLR1C', 'POLE3', 'POLR2E', 'POLR2I', 'POLE', 'POLR3K', 'POLR2K', 'POLR2L']",0.9999956783504922,0,0,13
406,PI3K-AKT-mTOR signaling pathway and therapeutic opportunities WP3844,0.8846163509174505,0.6044988731555896,0.07411230523224903,"['CDKN1B', 'BAD', 'FOXO4', 'HRAS']",0.9999956783504922,0,0,4
407,Regucalcin in proximal tubule epithelial kidney cells WP4838,0.8846163509174505,0.6044988731555896,0.07411230523224903,"['CASP8', 'PTH', 'TRPV5', 'TNFRSF1A']",0.9999956783504922,0,0,4
408,"4-hydroxytamoxifen, Dexamethasone, and Retinoic Acids Regulation of p27 Expression WP3879",0.8870673485411378,0.5240147329650092,0.0627949759710669,"['MKNK2', 'MAPK3']",0.9999956783504922,0,0,2
409,MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement WP4560,0.8870673485411378,0.5240147329650092,0.0627949759710669,"['JUN', 'MAPK3']",0.9999956783504922,0,0,2
410,Pyrimidine metabolism and related diseases WP4225,0.8870673485411378,0.5240147329650092,0.0627949759710669,"['RRM2', 'UPB1']",0.9999956783504922,0,0,2
411,Type II diabetes mellitus WP1584,0.8870673485411378,0.5240147329650092,0.0627949759710669,"['KCNJ11', 'SLC2A2']",0.9999956783504922,0,0,2
412,ESC Pluripotency Pathways WP3931,0.889327209752376,0.7498979257897116,0.08795556237932367,"['FZD1', 'JUN', 'FZD2', 'FZD7', 'WNT5A', 'FZD9', 'WNT7A', 'SMAD6', 'WNT16', 'FGF2', 'ELK1', 'FGF17', 'WNT6', 'SELENOP', 'FGFR4', 'HRAS', 'FGF10']",0.9999956783504922,0,0,17
413,Chemokine signaling pathway WP3929,0.891599391651835,0.7709821428571428,0.08846122649209603,"['LYN', 'CCR1', 'SHC3', 'CXCR5', 'ADCY4', 'CXCR4', 'PRKX', 'CXCL14', 'GNG11', 'CXCL5', 'CXCL16', 'GNG13', 'NFKBIA', 'FGR', 'HCK', 'GNG3', 'PARD3', 'GNB2', 'CCR9', 'RAC1', 'HRAS', 'MAPK3']",0.9999956783504922,0,0,22
414,TLR4 Signaling and Tolerance WP3851,0.8916735742632667,0.5613626495085462,0.06436312524667705,"['NFKBIA', 'IRF7', 'IRAK3']",0.9999956783504922,0,0,3
415,Integrated Cancer Pathway WP1971,0.8938595916125273,0.637033604400861,0.07147935732038475,"['BARD1', 'CDKN1B', 'CASP8', 'BAD', 'CHEK2', 'CDK2']",0.9999956783504922,0,0,6
416,Oxysterols derived from cholesterol WP4545,0.8956773074956322,0.6138547138512579,0.0676314914459869,"['CYP39A1', 'DBP', 'AKR1D1', 'THEM5', 'ACOT6']",0.9999956783504922,0,0,5
417,Autosomal recessive Osteopetrosis pathways WP4788,0.8963308887566392,0.4367424591119703,0.04779955738172173,['TCIRG1'],0.9999956783504922,0,0,1
418,Ethanol metabolism resulting in production of ROS by CYP2E1 WP4269,0.8963308887566392,0.4367424591119703,0.04779955738172173,['MAFK'],0.9999956783504922,0,0,1
419,TCA cycle in senescence WP5050,0.8963308887566392,0.4367424591119703,0.04779955738172173,['GOT1'],0.9999956783504922,0,0,1
420,Valproic acid pathway WP3871,0.8963308887566392,0.4367424591119703,0.04779955738172173,['CYP2A6'],0.9999956783504922,0,0,1
421,DNA damage response WP707,0.8969448059143599,0.6889802024440947,0.07493414182065565,"['CCNB2', 'CDKN1B', 'CASP8', 'RAD51', 'CDK5', 'CHEK2', 'H2AFX', 'CDK2', 'PMAIP1', 'CYCS']",0.9999956783504922,0,0,10
422,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.8969448059143599,0.6889802024440947,0.07493414182065565,"['YAP1', 'NFKBIA', 'CASP7', 'ANGPT2', 'RAD51', 'BAD', 'STMN1', 'RAC1', 'HRAS', 'MAPK3']",0.9999956783504922,0,0,10
423,G Protein Signaling Pathways WP35,0.8971808942013944,0.7232611739992998,0.07847222557605799,"['GNAZ', 'PRKCH', 'ADCY4', 'AKAP5', 'GNG11', 'GNG13', 'GNA14', 'GNG3', 'PRKAR1A', 'GNB2', 'GNAS', 'CALM1', 'HRAS', 'CALM2']",0.9999956783504922,0,0,14
424,Hair Follicle Development: Organogenesis - Part 2 of 3 WP2839,0.8997267448386734,0.5820690784759331,0.061503851068337174,"['FZD1', 'LEF1', 'WNT5A', 'GLI2']",0.9999956783504922,0,0,4
425,Neural Crest Differentiation WP2064,0.9034016604455192,0.7089144422893384,0.0720172129588535,"['MIA', 'DLX5', 'PAX3', 'ZIC5', 'TBX6', 'FGF2', 'GFAP', 'RHOB', 'DLL3', 'ZIC1', 'HES1', 'SOX9', 'HES5']",0.9999956783504922,0,0,13
426,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.9056489922894579,0.6668842596702683,0.0660905467138313,"['JUN', 'PRKCH', 'NOD2', 'HRAS', 'IFI44L', 'TNFRSF1A', 'TLR2', 'RELB', 'MAPK3']",0.9999956783504922,0,0,9
427,Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells WP4301,0.905679781902843,0.4912292817679558,0.048665828042990536,"['HRAS', 'MAPK3']",0.9999956783504922,0,0,2
428,TP53 network WP1742,0.905679781902843,0.4912292817679558,0.048665828042990536,"['CDKN2A', 'PMAIP1']",0.9999956783504922,0,0,2
429,Transcription co-factors SKI and SKIL protein partners WP4533,0.905679781902843,0.4912292817679558,0.048665828042990536,"['TEAD2', 'TEAD3']",0.9999956783504922,0,0,2
430,Gastrin signaling pathway WP4659,0.9057370350554457,0.7333130115376995,0.07260258114012776,"['CHGA', 'EGR1', 'JUN', 'PRKCH', 'CDKN1B', 'SERPINB2', 'CDKN2A', 'BAD', 'ELK1', 'RHOB', 'VEGFA', 'NFKBIA', 'CCKBR', 'RAC1', 'HRAS', 'CD44', 'MAPK3']",0.9999956783504922,0,0,17
431,Effect of progerin on genes involved in Hutchinson-Gilford progeria syndrome WP4320,0.9074038194364832,0.5358084855183501,0.05206327954561579,"['LEF1', 'H3F3A', 'HIST1H3E']",0.9999956783504922,0,0,3
432,EPO Receptor Signaling WP581,0.9074038194364832,0.5358084855183501,0.05206327954561579,"['PTPRC', 'CISH', 'MAPK3']",0.9999956783504922,0,0,3
433,Kisspeptin/kisspeptin receptor system in the ovary WP4871,0.9084717545855417,0.5952111661262891,0.0571352018166373,"['PRKCH', 'FSHR', 'HSD3B1', 'HRAS', 'MAPK3']",0.9999956783504922,0,0,5
434,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.9118223695815972,0.6991539416299434,0.06453895493732562,"['KLB', 'BAD', 'DIO1', 'DIO3', 'TRH', 'SLC5A5', 'MC4R', 'CREB3', 'TPO', 'PAX8', 'NPPA', 'PLIN1', 'HRAS']",0.9999956783504922,0,0,13
435,miRNA regulation of prostate cancer signaling pathways WP3981,0.9130620109393822,0.5612414119876806,0.051045737459535036,"['NFKBIA', 'CDKN1B', 'BAD', 'CREB3L1']",0.9999956783504922,0,0,4
436,AGE/RAGE pathway WP2324,0.9151394962241727,0.6544884214410923,0.058039228478567476,"['NFKBIA', 'LGALS3', 'JUN', 'CASP8', 'CYCS', 'RAC1', 'FOXO4', 'MAPK3', 'SOD1']",0.9999956783504922,0,0,9
437,miRNA regulation of DNA damage response WP1530,0.9158084039241152,0.6655310922161534,0.05853219652081363,"['CCNB2', 'CDKN1B', 'CASP8', 'RAD51', 'CDK5', 'CHEK2', 'H2AFX', 'CDK2', 'PMAIP1', 'CYCS']",0.9999956783504922,0,0,10
438,Leptin signaling pathway WP2034,0.9168399692008417,0.6748390335087233,0.05859110235833405,"['SOCS3', 'GSK3A', 'CISH', 'BAD', 'CFL2', 'LEP', 'LEPR', 'RAC1', 'ELK1', 'HRAS', 'MAPK3']",0.9999956783504922,0,0,11
439,Envelope proteins and their potential roles in EDMD physiopathology WP4535,0.9169864179403134,0.6042801225323349,0.052368497570116704,"['ADCY10', 'CFL1', 'ADCY4', 'BANF1', 'HRAS', 'MAPK3']",0.9999956783504922,0,0,6
440,Photodynamic therapy-induced AP-1 survival signaling. WP3611,0.9169864179403134,0.6042801225323349,0.052368497570116704,"['HSP90AA1', 'JUN', 'CDKN2A', 'BMF', 'ELK1', 'TNFRSF1A']",0.9999956783504922,0,0,6
441,Mevalonate arm of cholesterol biosynthesis pathway WP4190,0.9173616667143873,0.39304059652029827,0.03390112017211756,['IDI2'],0.9999956783504922,0,0,1
442,"NAD metabolism, sirtuins and aging WP3630",0.9173616667143873,0.39304059652029827,0.03390112017211756,['ROS1'],0.9999956783504922,0,0,1
443,Vitamin B12 Disorders WP4271,0.9173616667143873,0.39304059652029827,0.03390112017211756,['TCN1'],0.9999956783504922,0,0,1
444,Cytoplasmic Ribosomal Proteins WP477,0.919621955563547,0.6896572382856672,0.05778818086662124,"['RPL4', 'RPL3', 'RPS5', 'RPSA', 'RPS15', 'RPS26', 'RPL7A', 'RPL18A', 'RPS2', 'RPL15', 'RPL29', 'RPL18', 'UBA52']",0.9999956783504922,0,0,13
445,FGFR3 signaling in chondrocyte proliferation and terminal differentiation WP4767,0.9210332117235468,0.5124764227446928,0.042155891777008306,"['PPP2CA', 'SOX9', 'MAPK3']",0.9999956783504922,0,0,3
446,Ebstein-Barr virus LMP1 signaling WP262,0.9213894984279094,0.4623009424764381,0.0378496987566082,"['NFKBIA', 'HSP90AA1']",0.9999956783504922,0,0,2
447,GDNF/RET signaling axis WP4830,0.9213894984279094,0.4623009424764381,0.0378496987566082,"['FOXC1', 'PAX2']",0.9999956783504922,0,0,2
448,Disruption of postsynaptic signaling by CNV WP4875,0.9247912457206366,0.5418501362917215,0.04236577057400421,"['HOMER1', 'YWHAG', 'MAPK3', 'SHANK1']",0.9999956783504922,0,0,4
449,Type 2 papillary renal cell carcinoma WP4241,0.9247912457206366,0.5418501362917215,0.04236577057400421,"['EGLN3', 'EGLN2', 'ELOB', 'VEGFA']",0.9999956783504922,0,0,4
450,PI3K-Akt signaling pathway WP4172,0.9251107411407378,0.8097877893256087,0.06303536220467489,"['CDKN1B', 'CHRM1', 'FLT1', 'HSP90AB1', 'CSF1', 'ITGB4', 'TNC', 'FGF2', 'PPP2R1A', 'CREB3L1', 'RAC1', 'HRAS', 'HSP90AA1', 'IL4R', 'VWF', 'HGF', 'OSMR', 'PRLR', 'CREB3', 'ITGA8', 'EPHA2', 'TLR2', 'PKN3', 'EFNA4', 'PPP2CA', 'GNG3', 'RELN', 'SPP1', 'MAPK3', 'NTRK1', 'NGFR', 'ANGPT2', 'LAMB3', 'BDNF', 'LAMB2', 'BAD', 'LAMB1', 'IGF1', 'GNG11', 'GNG13', 'VEGFA', 'EFNA1', 'FGF17', 'EFNA3', 'IL7', 'GNB2', 'CDK2', 'FGFR4', 'PIK3AP1', 'FGF10']",0.9999956783504922,0,0,50
451,Hippo-Merlin Signaling Dysregulation WP4541,0.9265713289251799,0.7097589045946823,0.05412922962639495,"['NTRK1', 'NGFR', 'FLT1', 'ITGB4', 'ITGB2', 'CDH5', 'PPP1CC', 'PRKAR1A', 'CDH11', 'ITGA8', 'FGFR4', 'HRAS', 'CDH17', 'TEAD2', 'CD44', 'EPHA2', 'TEAD3']",0.9999956783504922,0,0,17
452,DNA damage response (only ATM dependent) WP710,0.9310447245558674,0.6977013619276514,0.049849341506320005,"['JUN', 'CDKN1B', 'MLKL', 'BIK', 'CDKN2A', 'BAD', 'WNT5A', 'LEF1', 'WNT7A', 'WNT16', 'WNT6', 'FRAT1', 'BCL6', 'PMAIP1', 'RAC1', 'HRAS']",0.9999956783504922,0,0,16
453,Melanoma WP4685,0.9316963458321572,0.631024870507295,0.044643953616768726,"['CDKN2A', 'BAD', 'CALM3', 'RAC1', 'CALM1', 'ELK1', 'HRAS', 'CALM2', 'MAPK3']",0.9999956783504922,0,0,9
454,T-cell receptor (TCR) signaling pathway WP69,0.9320011716163822,0.6542970552940091,0.046076388500040366,"['NFKBIA', 'ZAP70', 'JUN', 'CD83', 'FYB1', 'NFATC2', 'MAP3K8', 'NFATC1', 'VIM', 'HRAS', 'MAPK3']",0.9999956783504922,0,0,11
455,Gastric Cancer Network 2 WP2363,0.9328027979807922,0.4910886985355071,0.03416084874531985,"['PLAC8', 'S100A6', 'CACYBP']",0.9999956783504922,0,0,3
456,Lipid Metabolism Pathway WP3965,0.9328027979807922,0.4910886985355071,0.03416084874531985,"['PRKAR1A', 'FASN', 'PLIN1']",0.9999956783504922,0,0,3
457,MAPK and NFkB signaling pathways inhibited by Yersinia YopJ WP3849,0.9341269009119103,0.35728452712711206,0.02434643301819263,['NFKBIA'],0.9999956783504922,0,0,1
458,Serotonin and anxiety-related events WP3944,0.9341269009119103,0.35728452712711206,0.02434643301819263,['CRH'],0.9999956783504922,0,0,1
459,Cell cycle WP179,0.9341828188550945,0.706315205327414,0.04808814455974593,"['CDKN1C', 'CDKN2D', 'ANAPC13', 'CDKN1B', 'CDKN2C', 'YWHAB', 'CDKN2A', 'TTK', 'CDC14A', 'SMC1B', 'CCNB2', 'PTTG1', 'CHEK2', 'CDK2', 'BUB3', 'YWHAG', 'SKP1', 'YWHAH']",0.9999956783504922,0,0,18
460,Vitamin D in inflammatory diseases WP4482,0.9346080788283639,0.4365868631062001,0.029525498385133193,"['NFKBIA', 'NFATC1']",0.9999956783504922,0,0,2
461,Mesodermal commitment pathway WP2857,0.9374067869205895,0.7133410731411842,0.046108907019392596,"['YAP1', 'FOXC1', 'LEF1', 'HMGA2', 'ZIC5', 'TBX6', 'SMAD6', 'DKK1', 'GRHL2', 'TBX3', 'PPP2CA', 'ARL4A', 'TRIM28', 'ZIC2', 'PRKAR1A', 'ZIC3', 'C1QBP', 'BHLHE40', 'NODAL', 'TEAD2']",0.9999956783504922,0,0,20
462,MicroRNAs in cardiomyocyte hypertrophy WP1544,0.9386467682838501,0.6444859612213096,0.04080630480248765,"['FZD1', 'FZD2', 'CISH', 'NPPA', 'WNT5A', 'RAC1', 'IGF1', 'CALM1', 'FGF2', 'CALM2', 'MAPK3']",0.9999956783504922,0,0,11
463,Target Of Rapamycin (TOR) Signaling WP1471,0.9440661723142882,0.5068207350345049,0.029172103558639157,"['FKBP1A', 'RRAGA', 'DDIT4L', 'RAC1']",0.9999956783504922,0,0,4
464,miRNA targets in ECM and membrane receptors WP2911,0.9456995802819342,0.4135795289328293,0.023090281076218532,"['COL3A1', 'LAMB2']",0.9999956783504922,0,0,2
465,Purine metabolism and related disorders WP4224,0.9456995802819342,0.4135795289328293,0.023090281076218532,"['PRPS1', 'XDH']",0.9999956783504922,0,0,2
466,Eukaryotic Transcription Initiation WP405,0.9468782194645452,0.530714568591262,0.02896894338030994,"['TAF13', 'POLR2E', 'POLR2I', 'POLR3K', 'POLR2K']",0.9999956783504922,0,0,5
467,"GPCRs, Class C Metabotropic glutamate, pheromone WP501",0.9474915524405081,0.3274878026327902,0.01766379400269551,['GRM6'],0.9999956783504922,0,0,1
468,NO metabolism in cystic fibrosis WP4947,0.9474915524405081,0.3274878026327902,0.01766379400269551,['PRMT8'],0.9999956783504922,0,0,1
469,DNA IR-double strand breaks and cellular response via ATM WP3959,0.9479739716429534,0.5726025818349469,0.030593144259957676,"['YAP1', 'RAD51', 'TRIM28', 'CDK5', 'CDKN2A', 'CHEK2', 'H2AFX']",0.9999956783504922,0,0,7
470,IL-1 signaling pathway WP195,0.9479739716429534,0.5726025818349469,0.030593144259957676,"['NFKBIA', 'JUN', 'IL1R1', 'TOLLIP', 'HSPB2', 'IRAK3', 'MAPK3']",0.9999956783504922,0,0,7
471,PPAR signaling pathway WP3942,0.9479739716429534,0.5726025818349469,0.030593144259957676,"['CYP4A11', 'OLR1', 'LPL', 'ANGPTL4', 'PLIN1', 'CPT1B', 'ACSBG2']",0.9999956783504922,0,0,7
472,Autophagy WP4923,0.951632474904361,0.4532488787807937,0.022470436157146275,"['MAP1LC3B', 'ATG101', 'ATG9A']",0.9999956783504922,0,0,3
473,SARS-CoV-2 mitochondrial interactions WP5038,0.951632474904361,0.4532488787807937,0.022470436157146275,"['IRF7', 'PHB', 'NOX1']",0.9999956783504922,0,0,3
474,Trans-sulfuration and one-carbon metabolism WP2525,0.951632474904361,0.4532488787807937,0.022470436157146275,"['AHCY', 'SHMT2', 'MAT2B']",0.9999956783504922,0,0,3
475,Interleukin-11 Signaling Pathway WP2332,0.9538543209856268,0.516712017810631,0.02441170924191393,"['PTPA', 'SOCS3', 'BGLAP', 'HRAS', 'MAPK3']",0.9999956783504922,0,0,5
476,MAPK Signaling Pathway WP382,0.9543595065858498,0.755911779369108,0.03531229573780378,"['HSPB1', 'ELK1', 'FGF2', 'RELB', 'RPS6KA5', 'STMN1', 'MKNK2', 'MAP3K8', 'CD14', 'RAC1', 'CACNG1', 'HRAS', 'MAPK3', 'DUSP4', 'NTRK1', 'HSPA8', 'DAXX', 'JUN', 'DUSP2', 'JUND', 'DUSP3', 'HSPA1L', 'IL1R1', 'BDNF', 'IL1R2', 'NFATC1', 'MAPK8IP2', 'DUSP6', 'DUSP7', 'TNFRSF1A', 'TGFBR2', 'FGF17', 'NR4A1', 'PTPN7', 'FGFR4', 'HSPA1B', 'HSPA1A', 'FGF10']",0.9999956783504922,0,0,38
477,1q21.1 copy number variation syndrome WP4905,0.9549828829816018,0.3928729281767956,0.018096458696098446,"['PYGO2', 'GJA1']",0.9999956783504922,0,0,2
478,Hippo-Yap signaling pathway WP4537,0.9549828829816018,0.3928729281767956,0.018096458696098446,"['TEAD2', 'TEAD3']",0.9999956783504922,0,0,2
479,Immune response to tuberculosis WP4197,0.9549828829816018,0.3928729281767956,0.018096458696098446,"['TAP1', 'IFIT1']",0.9999956783504922,0,0,2
480,IL-9 signaling pathway WP22,0.9581452256738144,0.30227518959913324,0.012924053806008749,['MAPK3'],0.9999956783504922,0,0,1
481,Mammary gland development pathway - Embryonic development (Stage 1 of 4) WP2813,0.9581452256738144,0.30227518959913324,0.012924053806008749,['TERT'],0.9999956783504922,0,0,1
482,Omega-9 FA synthesis WP4724,0.9581452256738144,0.30227518959913324,0.012924053806008749,['FASN'],0.9999956783504922,0,0,1
483,Bladder cancer WP2828,0.9587195736859314,0.4760373218084661,0.020068144571756805,"['RPS6KA5', 'CDKN2A', 'HRAS', 'VEGFA']",0.9999956783504922,0,0,4
484,Neovascularisation processes WP4331,0.9587195736859314,0.4760373218084661,0.020068144571756805,"['ACVRL1', 'CXCR4', 'RELB', 'MAPK3']",0.9999956783504922,0,0,4
485,MET in type 1 papillary renal cell carcinoma WP4205,0.9595931199969596,0.5496210235131397,0.022669623501732718,"['JUN', 'BAD', 'HGF', 'RAC1', 'INSL3', 'HRAS', 'MAPK3']",0.9999956783504922,0,0,7
486,Notch Signaling WP268,0.959984806606484,0.503427546557212,0.02055888408164227,"['DTX3L', 'MFNG', 'HES1', 'HES5', 'DLL3']",0.9999956783504922,0,0,5
487,Nucleotide Excision Repair WP4753,0.959984806606484,0.503427546557212,0.02055888408164227,"['CETN2', 'POLD1', 'RPA3', 'POLE3', 'POLE']",0.9999956783504922,0,0,5
488,Ras signaling WP4223,0.9609415881258115,0.7078621307625756,0.028202398268006128,"['SHC3', 'FLT1', 'FOXO4', 'RASAL3', 'ELK1', 'ETS2', 'GNG3', 'HTR7', 'RAC1', 'HRAS', 'MAPK3', 'NTRK1', 'NGFR', 'PLA2G2C', 'BAD', 'GNG11', 'GNG13', 'ZAP70', 'GNB2', 'CALM3', 'CALM1', 'FGFR4', 'CALM2', 'PLA1A', 'EPHA2', 'ARF6']",0.9999956783504922,0,0,26
489,Wnt Signaling Pathway WP363,0.962048277390591,0.5234882005899705,0.020254096223855208,"['GSK3A', 'FRAT1', 'GJA1', 'LEF1', 'NFATC2', 'RAC1']",0.9999956783504922,0,0,6
490,RAS and bradykinin pathways in COVID-19 WP4969,0.9627350391675249,0.3741383846356222,0.014208670678703664,"['F12', 'REN']",0.9999956783504922,0,0,2
491,Focal Adhesion WP306,0.9638100751449606,0.7148893638398913,0.02635155204374422,"['SHC3', 'FLT1', 'ITGB4', 'TNC', 'ELK1', 'ACTB', 'MYL12B', 'ACTG1', 'PPP1CC', 'RELN', 'SPP1', 'RAC1', 'HRAS', 'MAPK3', 'JUN', 'VWF', 'LAMB3', 'LAMB2', 'BAD', 'HGF', 'LAMB1', 'IGF1', 'VEGFA', 'MYLPF', 'FGR', 'MYL5', 'HCK', 'PARVG', 'ITGA8']",0.9999956783504922,0,0,29
492,Tumor suppressor activity of SMARCB1 WP4204,0.9654377585828081,0.42081474756246795,0.014801588401679177,"['CDKN2A', 'H3F3A', 'GLI2']",0.9999956783504922,0,0,3
493,Cell Differentiation - Index expanded WP2023,0.9666377109104284,0.2806643784274273,0.009523365140207003,['ID2'],0.9999956783504922,0,0,1
494,Fatty acid transporters WP5061,0.9666377109104284,0.2806643784274273,0.009523365140207003,['ACSBG2'],0.9999956783504922,0,0,1
495,Overview of nanoparticle effects WP3287,0.9666377109104284,0.2806643784274273,0.009523365140207003,['HMOX1'],0.9999956783504922,0,0,1
496,Retinoblastoma gene in cancer WP2446,0.9678463948427205,0.5912641358406392,0.019323627858437664,"['BARD1', 'CCNB2', 'CDKN1B', 'RRM2', 'H2AFZ', 'RPA3', 'STMN1', 'CDK2', 'TTK', 'POLE', 'DCK']",0.9999956783504922,0,0,11
497,Gastric Cancer Network 1 WP2361,0.9691951207271806,0.3571069814163737,0.011173636180837984,"['H3F3A', 'GATD3B']",0.9999956783504922,0,0,2
498,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.9695633907312647,0.5606342177059033,0.01732887932220908,"['JUN', 'BAD', 'LEF1', 'PMAIP1', 'CYCS', 'RAC1', 'NTN1', 'TGFBR2', 'MAPK3']",0.9999956783504922,0,0,9
499,Fatty acid beta-oxidation WP143,0.9708558974866653,0.40627530943011503,0.012016497457798203,"['TPI1', 'LPL', 'CPT1B']",0.9999956783504922,0,0,3
500,DNA IR-damage and cellular response via ATR WP4016,0.9720173014263709,0.5686760717094388,0.016139979367204908,"['BARD1', 'SEM1', 'FEN1', 'BRIP1', 'RAD51', 'TRIM28', 'BCL6', 'CHEK2', 'H2AFX', 'CDK2']",0.9999956783504922,0,0,10
501,NAD+ metabolism WP3644,0.9734073249219809,0.26193500874528214,0.007059844321730199,['NRK'],0.9999956783504922,0,0,1
502,SREBF and miR33 in cholesterol and lipid homeostasis WP2011,0.9734073249219809,0.26193500874528214,0.007059844321730199,['FASN'],0.9999956783504922,0,0,1
503,Glycosylation and related congenital defects WP4521,0.9745682273650716,0.34155656978140764,0.008798753335545542,"['DOLK', 'MGAT2']",0.9999956783504922,0,0,2
504,MTHFR deficiency WP4288,0.9745682273650716,0.34155656978140764,0.008798753335545542,"['ASMT', 'CYCS']",0.9999956783504922,0,0,2
505,Signal Transduction of S1P Receptor WP26,0.9745682273650716,0.34155656978140764,0.008798753335545542,"['S1PR1', 'MAPK3']",0.9999956783504922,0,0,2
506,Wnt/beta-catenin signaling pathway in leukemia WP3658,0.9745682273650716,0.34155656978140764,0.008798753335545542,"['LEF1', 'DKK1']",0.9999956783504922,0,0,2
507,BDNF-TrkB Signaling WP3676,0.9754623218671794,0.39270516717325227,0.009756266678548306,"['HOMER1', 'BDNF', 'HRAS']",0.9999956783504922,0,0,3
508,TGF-beta Signaling Pathway WP366,0.9756384047641316,0.6358250592434832,0.015681511208656324,"['KLF10', 'YAP1', 'JUN', 'JUND', 'CITED1', 'ITGB4', 'TGFB1I1', 'LIMK2', 'TNC', 'NEDD9', 'TGFBR2', 'PJA1', 'TGFBR3', 'CCNB2', 'PARD6A', 'TERT', 'RAC1', 'SKP1']",0.9999956783504922,0,0,18
509,Hepatitis B infection WP4666,0.9757859928672896,0.6421707963670121,0.01574088170843283,"['JUN', 'TICAM2', 'EGR3', 'ATP6AP1', 'SLC10A1', 'YWHAB', 'BAD', 'NFATC2', 'NFATC1', 'ELK1', 'TGFBR2', 'CREB3', 'CASP8', 'CREB3L1', 'IRF7', 'CYCS', 'HRAS', 'TLR2', 'MAPK3']",0.9999956783504922,0,0,19
510,Genotoxicity pathway WP4286,0.9782095476977447,0.4806190175185118,0.010588695619491174,"['CEBPD', 'EI24', 'ID2', 'PCDH8', 'TRIAP1', 'HIST1H2BC']",0.9999956783504922,0,0,6
511,Canonical and non-canonical TGF-B signaling WP3874,0.9788035078684967,0.24554681027340514,0.005260684137735848,['TGFBR2'],0.9999956783504922,0,0,1
512,Synaptic signaling pathways associated with autism spectrum disorder WP4539,0.9808490590530853,0.44606278432653884,0.00862538029018645,"['GRIN3B', 'HOMER1', 'BDNF', 'HRAS', 'MAPK3']",0.9999956783504922,0,0,5
513,Pathways affected in adenoid cystic carcinoma WP3651,0.9817439217144378,0.49052558782849237,0.009037824480013524,"['MORF4L1', 'CEBPA', 'UHRF1', 'CHEK2', 'INSRR', 'FGFR4', 'HRAS']",0.9999956783504922,0,0,7
514,Arrhythmogenic Right Ventricular Cardiomyopathy WP2118,0.9826147480068319,0.506274880839745,0.00887912489956608,"['GJA1', 'ACTN3', 'ITGB4', 'LEF1', 'ITGA8', 'CACNG1', 'ACTB', 'ACTG1']",0.9999956783504922,0,0,8
515,Overview of interferons-mediated signaling pathway WP4558,0.9831048408114604,0.2310866351511607,0.003937603167756697,['IFNE'],0.9999956783504922,0,0,1
516,Simplified Interaction Map Between LOXL4 and Oxidative Stress Pathway WP3670,0.9831048408114604,0.2310866351511607,0.003937603167756697,['IGFBP7'],0.9999956783504922,0,0,1
517,Notch Signaling Pathway Netpath WP61,0.9836314188754383,0.46170614263404475,0.00762001037351251,"['PSENEN', 'HEY1', 'HES1', 'HES5', 'SKP1', 'DLL3']",0.9999956783504922,0,0,6
518,Head and Neck Squamous Cell Carcinoma WP4674,0.9847640258688397,0.4982036348942824,0.007649037064305105,"['FKBP1A', 'CASP8', 'TERT', 'CDKN2A', 'KEAP1', 'HRAS', 'TGFBR2', 'VEGFA']",0.9999956783504922,0,0,8
519,Glycerophospholipid Biosynthetic Pathway WP2533,0.985788435577764,0.3020824479388015,0.004323861886079377,"['GPD1', 'CDIPT']",0.9999956783504922,0,0,2
520,Resistin as a regulator of inflammation WP4481,0.985788435577764,0.3020824479388015,0.004323861886079377,"['NFKBIA', 'MAPK3']",0.9999956783504922,0,0,2
521,Host-pathogen interaction of human coronaviruses - autophagy WP4863,0.9865334107934918,0.2182331461536101,0.002958823781349274,['MAP1LC3A'],0.9999956783504922,0,0,1
522,PPAR-alpha pathway WP2878,0.9865334107934918,0.2182331461536101,0.002958823781349274,['CYP4A11'],0.9999956783504922,0,0,1
523,Small cell lung cancer WP4658,0.9887859111109272,0.5260349474167686,0.005932328005672189,"['CDKN1C', 'NFKBIA', 'CDKN1B', 'CASP8', 'LAMB3', 'LAMB2', 'CDK2', 'CKS2', 'CYCS', 'LAMB1', 'SKP1']",0.9999956783504922,0,0,11
524,Interferon type I signaling pathways WP585,0.9896486615396536,0.40877568887660126,0.0042534280239791555,"['ZAP70', 'SOCS3', 'RPS6KA5', 'PTPRC', 'RAC1']",0.9999956783504922,0,0,5
525,Novel intracellular components of RIG-I-like receptor (RLR) pathway WP3865,0.9896486615396536,0.40877568887660126,0.0042534280239791555,"['DDX3Y', 'NFKBIA', 'CASP8', 'IFNE', 'IRF7']",0.9999956783504922,0,0,5
526,Histone Modifications WP2369,0.9902734997778924,0.37379241359340865,0.0036534887675719854,"['SET', 'H3F3A', 'SMYD1', 'HIST1H3E']",0.9999956783504922,0,0,4
527,Translation inhibitors in chronically activated PDGFRA cells WP4566,0.9902734997778924,0.37379241359340865,0.0036534887675719854,"['EIF4A2', 'RPS6KA5', 'PIM1', 'MAPK3']",0.9999956783504922,0,0,4
528,Glycerolipids and Glycerophospholipids WP4722,0.9914445445169641,0.1963822148577741,0.0016873677332615142,['CDIPT'],0.9999956783504922,0,0,1
529,Kallmann's Syndrome WP5074,0.9914445445169641,0.1963822148577741,0.0016873677332615142,['PROKR2'],0.9999956783504922,0,0,1
530,Hedgehog Signaling Pathway WP4249,0.9915019696972014,0.32711614626508245,0.00279172186447192,"['EVC2', 'EVC', 'GLI2']",0.9999956783504922,0,0,3
531,Fatty Acid Biosynthesis WP357,0.9931807612384254,0.18701753001670152,0.001279685405922927,['FASN'],0.9999956783504922,0,0,1
532,NAD+ biosynthetic pathways WP3645,0.9931807612384254,0.18701753001670152,0.001279685405922927,['ACMSD'],0.9999956783504922,0,0,1
533,Nanoparticle triggered autophagic cell death WP2509,0.9931807612384254,0.18701753001670152,0.001279685405922927,['MAP1LC3A'],0.9999956783504922,0,0,1
534,PKC-gamma calcium signaling pathway in ataxia WP4760,0.9931807612384254,0.18701753001670152,0.001279685405922927,['GNA14'],0.9999956783504922,0,0,1
535,AMP-activated protein kinase (AMPK) signaling WP1403,0.9932714839803292,0.4129308337214718,0.0027878011653068822,"['STRADB', 'FASN', 'LEP', 'LEPR', 'EEF2', 'CPT1B']",0.9999956783504922,0,0,6
536,Endometrial cancer WP4155,0.9932714839803292,0.4129308337214718,0.0027878011653068822,"['BAD', 'LEF1', 'FGF2', 'ELK1', 'HRAS', 'MAPK3']",0.9999956783504922,0,0,6
537,Sphingolipid Metabolism (general overview) WP4725,0.9945646070940477,0.178504180161181,0.0009728867671855433,['SGMS2'],0.9999956783504922,0,0,1
538,Host-pathogen interaction of human coronaviruses - interferon induction WP4880,0.9947138375612409,0.25327036178934237,0.0013423794253798105,"['NFKBIA', 'JUN']",0.9999956783504922,0,0,2
539,Pancreatic adenocarcinoma pathway WP4263,0.9950041975857772,0.4582478136311516,0.002295053134944177,"['RAD51', 'CDKN2A', 'BAD', 'PEBP1', 'RAC1', 'DUSP6', 'TGFBR2', 'MAPK3', 'VEGFA']",0.9999956783504922,0,0,9
540,Sphingolipid Metabolism (integrated pathway) WP4726,0.9956675795818998,0.17073112159744486,0.0007412859403909497,['SGMS2'],0.9999956783504922,0,0,1
541,Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway WP4577,0.9959018904503676,0.2943216358109975,0.001208640572133966,"['MAP1LC3A', 'ATG101', 'CP']",0.9999956783504922,0,0,3
542,Kit receptor signaling pathway WP304,0.996031810300871,0.3632025722155664,0.0014441238832862127,"['LYN', 'BAD', 'HRAS', 'MAPK3', 'TBX2']",0.9999956783504922,0,0,5
543,Glioblastoma signaling pathways WP2261,0.9966903884561823,0.42381728712663963,0.0014049968674691102,"['CDKN1B', 'PRKCH', 'CDKN2C', 'CDKN2A', 'CDK2', 'FOXO4', 'HRAS', 'MAPK3']",0.9999956783504922,0,0,8
544,Ectoderm Differentiation WP2858,0.9967103660311109,0.5153721564793603,0.0016981804826309566,"['TFAP2C', 'ARHGDIG', 'STC1', 'PAX3', 'TNFRSF11B', 'NFATC1', 'NR2F2', 'JAKMIP1', 'CELSR2', 'VAX2', 'EDA2R', 'SDCBP', 'PIM1', 'HESX1', 'LY6E']",0.9999956783504922,0,0,15
545,Joubert Syndrome WP4656,0.9967470050356775,0.4036205353510699,0.0013151157630720512,"['TMEM17', 'CETN2', 'ARL2', 'UNC119', 'PDE6B', 'PDE6A', 'ARR3']",0.9999956783504922,0,0,7
546,Thermogenesis WP4321,0.996854303035701,0.46852612187398407,0.0014761642010860225,"['KLB', 'ADCY10', 'CREB3', 'CREB3L1', 'GNAS', 'ADCY4', 'PLIN1', 'CPT1B', 'HRAS', 'ACTB', 'ACTG1']",0.9999956783504922,0,0,11
547,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.9971369391579037,0.4181368751152924,0.00119886835040673,"['SHC3', 'BAD', 'HGF', 'IGF1', 'FGF2', 'HRAS', 'MAPK3', 'VEGFA']",0.9999956783504922,0,0,8
548,Fragile X Syndrome  WP4549,0.9974539904288113,0.4849806700180765,0.001236339963095312,"['GABRA1', 'DUSP3', 'HOMER1', 'BDNF', 'CDKN2A', 'GAD1', 'AKAP5', 'EEF1A1', 'PRKAR1A', 'AP2S1', 'GABRD', 'AP2M1', 'SHANK1']",0.9999956783504922,0,0,13
549,Endoderm differentiation WP2853,0.9975777540227381,0.49398234154331716,0.0011979982493211462,"['DUSP4', 'DUSP5', 'DUSP2', 'ONECUT1', 'LEF1', 'PAX3', 'ZIC5', 'DKK1', 'GRHL2', 'GLI2', 'ZIC3', 'C1QBP', 'TCEAL2', 'NODAL']",0.9999956783504922,0,0,14
550,DNA Repair Pathways Full Network WP4946,0.9977573692580105,0.48037139854765604,0.0010785054632356187,"['FEN1', 'CENPX', 'OGG1', 'CETN2', 'H2AFX', 'BRIP1', 'NEIL2', 'RAD51', 'POLD1', 'TDG', 'RPA3', 'POLE3', 'POLE']",0.9999956783504922,0,0,13
551,Insulin Signaling WP481,0.9977766234546298,0.5350397450565776,0.0011909192421004687,"['EGR1', 'XBP1', 'JUN', 'ARF1', 'GSK3A', 'PRKCH', 'SHC3', 'STXBP2', 'PPP1R3A', 'ELK1', 'EHD1', 'SOCS3', 'RPS6KA5', 'MAP3K8', 'RAC1', 'HRAS', 'VAMP2', 'ARF6', 'MAPK3']",0.9999956783504922,0,0,19
552,Nanoparticle-mediated activation of receptor signaling WP2643,0.9978057278503484,0.1509995113971916,0.0003316980736277679,['HRAS'],0.9999956783504922,0,0,1
553,Non-small cell lung cancer WP4255,0.9980651039368562,0.3619043567052417,0.00070092564304747,"['CASP8', 'CDKN2A', 'BAD', 'CYCS', 'HRAS', 'MAPK3']",0.9999956783504922,0,0,6
554,Integrated breast cancer pathway WP1984,0.9985784190014044,0.5040768293195478,0.0007170958681735459,"['BARD1', 'JUN', 'GSK3A', 'BAD', 'ODC1', 'PHB', 'SMAD6', 'JAKMIP1', 'TFPI', 'TGFBR2', 'VEGFA', 'CASP8', 'RAD51', 'CHEK2', 'CDK2', 'RHO', 'RAC1']",0.9999956783504922,0,0,17
555,Integrin-mediated Cell Adhesion WP185,0.9987843312873835,0.4052893287649007,0.0004929972779715563,"['SHC3', 'CAPNS1', 'ITGB4', 'SELENOP', 'ITGB2', 'ITGA8', 'RHO', 'RAC1', 'HRAS']",0.9999956783504922,0,0,9
556,EGF/EGFR signaling pathway WP437,0.9989440211774764,0.5030838750594577,0.0005315266078544754,"['JUN', 'JUND', 'LIMK2', 'PEBP1', 'FOXO4', 'ELK1', 'EPN1', 'GJA1', 'PLSCR1', 'RPS6KA5', 'NEDD4', 'CFL1', 'STMN1', 'AP2S1', 'RAC1', 'HRAS', 'AP2M1', 'ARF6']",0.9999956783504922,0,0,18
557,Splicing factor NOVA regulated synaptic proteins WP4148,0.9989518139987633,0.2012041365632526,0.00021100996751329538,"['STXBP2', 'NCDN']",0.9999956783504922,0,0,2
558,Regulation of Actin Cytoskeleton WP51,0.999152377856509,0.4696534516218464,0.00039825747514358155,"['CHRM1', 'BRK1', 'FGF2', 'ACTB', 'ACTG1', 'FGF17', 'VIL1', 'CFL2', 'CFL1', 'CD14', 'RAC1', 'PFN1', 'FGFR4', 'FGF10', 'MAPK3']",0.9999956783504922,0,0,15
559,Ciliary landscape WP4352,0.9991572561133537,0.5493821964344767,0.00046318368751296815,"['YAP1', 'SSNA1', 'VPS4A', 'COPS7A', 'PSMD8', 'EXOSC4', 'ARHGDIA', 'CDH23', 'NEFL', 'STOM', 'NEFM', 'RAC1', 'TFAP2C', 'RHBDD2', 'DYNLT3', 'H3F3A', 'DYNLL1', 'DYNLL2', 'LSM4', 'CD2BP2', 'DYNLRB1', 'VIM', 'CALM1', 'YPEL5', 'COPS8', 'CALM2']",0.9999956783504922,0,0,26
560,p53 transcriptional gene network WP4963,0.9994033192043097,0.27037227654829304,0.00016137409430416852,"['PMAIP1', 'SLC7A11', 'RPRM', 'TNFRSF10D']",0.9999956783504922,0,0,4
561,Cholesterol metabolism (includes both Bloch and Kandutsch-Russell pathways) WP4718,0.999432883303853,0.18679294922388845,0.00010596344988901824,"['FASN', 'DHCR24']",0.9999956783504922,0,0,2
562,Ciliopathies WP4803,0.9994799342942677,0.49813090392103465,0.00025912818777868655,"['EVC2', 'DNAH11', 'RSPH4A', 'DNAAF3', 'DCDC2', 'GLI2', 'RP1L1', 'RPGRIP1', 'TMEM17', 'BBS10', 'EVC', 'ARL2BP', 'ZIC2', 'MAK', 'CNGA1', 'UNC119', 'NEK2', 'CCDC65', 'CCDC151', 'CCNO']",0.9999956783504922,0,0,20
563,Male infertility WP4673,0.9995496910932661,0.3915282392026578,0.00017634836195047968,"['CYP26B1', 'ABCB1', 'MSH5', 'DND1', 'HMGA1', 'HLA-DRA', 'TEX15', 'CLU', 'SOD3', 'ETV5']",0.9999956783504922,0,0,10
564,ErbB signaling pathway WP673,0.9996326546469119,0.33437911142596904,0.00012285517927346028,"['JUN', 'CDKN1B', 'SHC3', 'BAD', 'ELK1', 'HRAS', 'MAPK3']",0.9999956783504922,0,0,7
565,Sterol regulatory element-binding proteins (SREBP) signaling WP1982,0.9996534321325331,0.2570209063969769,8.909062629046353e-05,"['GSK3A', 'RBP4', 'FASN', 'LPL']",0.9999956783504922,0,0,4
566,Rett syndrome causing genes WP4312,0.9999783390806862,0.08340825092398362,1.8067189610346092e-06,['GABRD'],0.9999956783504922,0,0,1
567,Phosphoinositides metabolism WP4971,0.9999820952949557,0.081664825554635,1.4621977041949094e-06,['PIP4P1'],0.9999956783504922,0,0,1
568,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.9999825989257379,0.30334424539736776,5.278561667585843e-06,"['GSK3A', 'RPS6KA5', 'SHC3', 'FASN', 'TRIP10', 'LPL', 'MAP3K8', 'HRAS', 'MAPK3']",0.9999956783504922,0,0,9
569,Genes related to primary cilium development (based on CRISPR) WP4536,0.9999879322409225,0.24196583340936045,2.920003001545698e-06,"['EVC2', 'TMEM17', 'BBS10', 'EVC', 'TULP3', 'DYNLL1']",0.9999956783504922,0,0,6
570,mRNA Processing WP411,0.9999956783504922,0.16132496452701545,6.97191460055328e-07,"['SF3B5', 'CD2BP2', 'CSTF2T', 'SNU13', 'HNRNPH2']",0.9999956783504922,0,0,5
